Author: "Goldstein, Rita Z." / Database: OAIster - Searchworks@Jio Institute Digital Library Search Results

Your search keyword '"Goldstein, Rita Z."' showing total 29 results

Start Over Author "Goldstein, Rita Z." Database OAIster

29 results on '"Goldstein, Rita Z."'

1. Parameter Space and Potential for Biomarker Development in 25 Years of fMRI Drug Cue Reactivity

Author: Sangchooli, Arshiya, Zare-Bidoky, Mehran, Jouzdani, Ali Fathi, Schacht, Joseph, Bjork, James M., Claus, Eric D., Prisciandaro, James J., Wilson, Stephen J., Wuestenberg, Torsten, Potvin, Stephane, Ahmadi, Pooria, Bach, Patrick, Baldacchino, Alex, Beck, Anne, Brady, Kathleen T., Brewer, Judson A., Childress, Anna Rose, Courtney, Kelly E., Ebrahimi, Mohsen, Filbey, Francesca M., Garavan, Hugh, Ghahremani, Dara G., Goldstein, Rita Z., Goudriaan, Anneke E., Grodin, Erica N., Hanlon, Colleen A., Haugg, Amelie, Heilig, Markus, Heinz, Andreas, Holczer, Adrienn, Van Holst, Ruth J., Joseph, Jane E., Juliano, Anthony C., Kaufman, Marc J., Kiefer, Falk, Zonoozi, Arash Khojasteh, Kuplicki, Rayus T., Leyton, Marco, London, Edythe D., Mackey, Scott, McClernon, F. Joseph, Mellick, William H., Morley, Kirsten, Noori, Hamid R., Oghabian, Mohammad Ali, Oliver, Jason A., Owens, Max, Paulus, Martin P., Perini, Irene, Rafei, Parnian, Ray, Lara A., Sinha, Rajita, Smolka, Michael N., Soleimani, Ghazaleh, Spanagel, Rainer, Steele, Vaughn R., Tapert, Susan F., Vollstaedt-Klein, Sabine, Wetherill, Reagan R., Witkiewitz, Katie, Yuan, Kai, Zhang, Xiaochu, Verdejo-Garcia, Antonio, Potenza, Marc N., Janes, Amy C., Kober, Hedy, Zilverstand, Anna, Ekhtiari, Hamed, Sangchooli, Arshiya, Zare-Bidoky, Mehran, Jouzdani, Ali Fathi, Schacht, Joseph, Bjork, James M., Claus, Eric D., Prisciandaro, James J., Wilson, Stephen J., Wuestenberg, Torsten, Potvin, Stephane, Ahmadi, Pooria, Bach, Patrick, Baldacchino, Alex, Beck, Anne, Brady, Kathleen T., Brewer, Judson A., Childress, Anna Rose, Courtney, Kelly E., Ebrahimi, Mohsen, Filbey, Francesca M., Garavan, Hugh, Ghahremani, Dara G., Goldstein, Rita Z., Goudriaan, Anneke E., Grodin, Erica N., Hanlon, Colleen A., Haugg, Amelie, Heilig, Markus, Heinz, Andreas, Holczer, Adrienn, Van Holst, Ruth J., Joseph, Jane E., Juliano, Anthony C., Kaufman, Marc J., Kiefer, Falk, Zonoozi, Arash Khojasteh, Kuplicki, Rayus T., Leyton, Marco, London, Edythe D., Mackey, Scott, McClernon, F. Joseph, Mellick, William H., Morley, Kirsten, Noori, Hamid R., Oghabian, Mohammad Ali, Oliver, Jason A., Owens, Max, Paulus, Martin P., Perini, Irene, Rafei, Parnian, Ray, Lara A., Sinha, Rajita, Smolka, Michael N., Soleimani, Ghazaleh, Spanagel, Rainer, Steele, Vaughn R., Tapert, Susan F., Vollstaedt-Klein, Sabine, Wetherill, Reagan R., Witkiewitz, Katie, Yuan, Kai, Zhang, Xiaochu, Verdejo-Garcia, Antonio, Potenza, Marc N., Janes, Amy C., Kober, Hedy, Zilverstand, Anna, and Ekhtiari, Hamed
Abstract: Importance In the last 25 years, functional magnetic resonance imaging drug cue reactivity (FDCR) studies have characterized some core aspects in the neurobiology of drug addiction. However, no FDCR-derived biomarkers have been approved for treatment development or clinical adoption. Traversing this translational gap requires a systematic assessment of the FDCR literature evidence, its heterogeneity, and an evaluation of possible clinical uses of FDCR-derived biomarkers. Objective To summarize the state of the field of FDCR, assess their potential for biomarker development, and outline a clear process for biomarker qualification to guide future research and validation efforts. Evidence Review The PubMed and Medline databases were searched for every original FDCR investigation published from database inception until December 2022. Collected data covered study design, participant characteristics, FDCR task design, and whether each study provided evidence that might potentially help develop susceptibility, diagnostic, response, prognostic, predictive, or severity biomarkers for 1 or more addictive disorders. Findings There were 415 FDCR studies published between 1998 and 2022. Most focused on nicotine (122 [29.6%]), alcohol (120 [29.2%]), or cocaine (46 [11.1%]), and most used visual cues (354 [85.3%]). Together, these studies recruited 19 311 participants, including 13 812 individuals with past or current substance use disorders. Most studies could potentially support biomarker development, including diagnostic (143 [32.7%]), treatment response (141 [32.3%]), severity (84 [19.2%]), prognostic (30 [6.9%]), predictive (25 [5.7%]), monitoring (12 [2.7%]), and susceptibility (2 [0.5%]) biomarkers. A total of 155 interventional studies used FDCR, mostly to investigate pharmacological (67 [43.2%]) or cognitive/behavioral (51 [32.9%]) interventions; 141 studies used FDCR as a response measure, of which 125 (88.7%) reported significant interventional FDCR alterations; and 25, Funding Agencies|Deutsche Forschungsgemeinschaft
Published: 2024
Full Text: View/download PDF

2. A methodological checklist for fMRI drug cue reactivity studies : development and expert consensus

Author: Ekhtiari, Hamed, Zare-Bidoky, Mehran, Sangchooli, Arshiya, Janes, Amy C., Kaufman, Marc J., Oliver, Jason A., Prisciandaro, James J., Wustenberg, Torsten, Anton, Raymond F., Bach, Patrick, Baldacchino, Alex, Beck, Anne, Bjork, James M., Brewer, Judson, Childress, Anna Rose, Claus, Eric D., Courtney, Kelly E., Ebrahimi, Mohsen, Filbey, Francesca M., Ghahremani, Dara G., Azbari, Peyman Ghobadi, Goldstein, Rita Z., Goudriaan, Anna E., Grodin, Erica N., Hamilton, Paul, Hanlon, Colleen A., Hassani-Abharian, Peyman, Heinz, Andreas, Joseph, Jane E., Kiefer, Falk, Zonoozi, Arash Khojasteh, Kober, Hedy, Kuplicki, Rayus, Li, Qiang, London, Edythe D., McClernon, Joseph, Noori, Hamid R., Owens, Max M., Paulus, Martin, Perini, Irene, Potenza, Marc, Potvin, Stephane, Ray, Lara, Schacht, Joseph P., Seo, Dongju, Sinha, Rajita, Smolka, Michael N., Spanagel, Rainer, Steele, Vaughn R., Stein, Elliot A., Steins-Loeber, Sabine, Tapert, Susan F., Verdejo-Garcia, Antonio, Vollstaedt-Klein, Sabine, Wetherill, Reagan R., Wilson, Stephen J., Witkiewitz, Katie, Yuan, Kai, Zhang, Xiaochu, Zilverstand, Anna, Ekhtiari, Hamed, Zare-Bidoky, Mehran, Sangchooli, Arshiya, Janes, Amy C., Kaufman, Marc J., Oliver, Jason A., Prisciandaro, James J., Wustenberg, Torsten, Anton, Raymond F., Bach, Patrick, Baldacchino, Alex, Beck, Anne, Bjork, James M., Brewer, Judson, Childress, Anna Rose, Claus, Eric D., Courtney, Kelly E., Ebrahimi, Mohsen, Filbey, Francesca M., Ghahremani, Dara G., Azbari, Peyman Ghobadi, Goldstein, Rita Z., Goudriaan, Anna E., Grodin, Erica N., Hamilton, Paul, Hanlon, Colleen A., Hassani-Abharian, Peyman, Heinz, Andreas, Joseph, Jane E., Kiefer, Falk, Zonoozi, Arash Khojasteh, Kober, Hedy, Kuplicki, Rayus, Li, Qiang, London, Edythe D., McClernon, Joseph, Noori, Hamid R., Owens, Max M., Paulus, Martin, Perini, Irene, Potenza, Marc, Potvin, Stephane, Ray, Lara, Schacht, Joseph P., Seo, Dongju, Sinha, Rajita, Smolka, Michael N., Spanagel, Rainer, Steele, Vaughn R., Stein, Elliot A., Steins-Loeber, Sabine, Tapert, Susan F., Verdejo-Garcia, Antonio, Vollstaedt-Klein, Sabine, Wetherill, Reagan R., Wilson, Stephen J., Witkiewitz, Katie, Yuan, Kai, Zhang, Xiaochu, and Zilverstand, Anna
Abstract: Cue reactivity measured by functional magnetic resonance imaging is used in studies of substance-use disorders. This Consensus Statement is the result of a Delphi process to arrive at parameters that should be reported in describing these studies. Cue reactivity is one of the most frequently used paradigms in functional magnetic resonance imaging (fMRI) studies of substance use disorders (SUDs). Although there have been promising results elucidating the neurocognitive mechanisms of SUDs and SUD treatments, the interpretability and reproducibility of these studies is limited by incomplete reporting of participants characteristics, task design, craving assessment, scanning preparation and analysis decisions in fMRI drug cue reactivity (FDCR) experiments. This hampers clinical translation, not least because systematic review and meta-analysis of published work are difficult. This consensus paper and Delphi study aims to outline the important methodological aspects of FDCR research, present structured recommendations for more comprehensive methods reporting and review the FDCR literature to assess the reporting of items that are deemed important. Forty-five FDCR scientists from around the world participated in this study. First, an initial checklist of items deemed important in FDCR studies was developed by several members of the Enhanced NeuroImaging Genetics through Meta-Analyses (ENIGMA) Addiction working group on the basis of a systematic review. Using a modified Delphi consensus method, all experts were asked to comment on, revise or add items to the initial checklist, and then to rate the importance of each item in subsequent rounds. The reporting status of the items in the final checklist was investigated in 108 recently published FDCR studies identified through a systematic review. By the final round, 38 items reached the consensus threshold and were classified under seven major categories: Participants Characteristics, General fMRI Information, General Task Inf, Funding Agencies|National Institute on Alcohol Abuse and Alcoholism (NIAAA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [P50 AA010761]; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)German Research Foundation (DFG) [402170461-TRR 265, 40217046-TRR 265, 421888313, 437718741, 324164820]; DFGGerman Research Foundation (DFG)European Commission [402170461 - TRR 265]; California Tobacco-Related Disease Research Grant Program of the University of California [T30IP0962]; Laureate Institute for Brain Research (LIBR); Warren K. Family Foundation; Oklahoma Center for Advancement of Science and Technologies (OCAST) [HR18-139]; Brain and Behavior Foundation (NARSAD Young Investigator Award) [27305]; National Institute on Drug Abuse (NIDA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [R01 DA030344, R21DA044465]; NIDAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [R01DA041528, R01DA048301, R01DA047851, K23DA042898, K12 DA000167, U01 DA041089, U24 DA041147, P30 DA048742]; NCCIH [R01AT010627]; NIAAAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [F32AA027699, R01 AA027765, R01 AA026859, U01 AA021692, U24 AA021695, R01AA023665, R01AA022328]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01DA039135, K02DA042987, R01 DA041866, R01AA026844, K08AA023545, K23AA023894, R01DA040670, R21HL144673, R01DA041438, R21DA045853]; Bundesministerium fur Bildung und ForschungFederal Ministry of Education & Research (BMBF) [FKZ: 01ZX1503, 01ZX1909B]; Shanghai Municipal Science and Technology Major project [2019SHZ
Published: 2022
Full Text: View/download PDF

3. A methodological checklist for fMRI drug cue reactivity studies : development and expert consensus

Author: Ekhtiari, Hamed, Zare-Bidoky, Mehran, Sangchooli, Arshiya, Janes, Amy C., Kaufman, Marc J., Oliver, Jason A., Prisciandaro, James J., Wustenberg, Torsten, Anton, Raymond F., Bach, Patrick, Baldacchino, Alex, Beck, Anne, Bjork, James M., Brewer, Judson, Childress, Anna Rose, Claus, Eric D., Courtney, Kelly E., Ebrahimi, Mohsen, Filbey, Francesca M., Ghahremani, Dara G., Azbari, Peyman Ghobadi, Goldstein, Rita Z., Goudriaan, Anna E., Grodin, Erica N., Hamilton, Paul, Hanlon, Colleen A., Hassani-Abharian, Peyman, Heinz, Andreas, Joseph, Jane E., Kiefer, Falk, Zonoozi, Arash Khojasteh, Kober, Hedy, Kuplicki, Rayus, Li, Qiang, London, Edythe D., McClernon, Joseph, Noori, Hamid R., Owens, Max M., Paulus, Martin, Perini, Irene, Potenza, Marc, Potvin, Stephane, Ray, Lara, Schacht, Joseph P., Seo, Dongju, Sinha, Rajita, Smolka, Michael N., Spanagel, Rainer, Steele, Vaughn R., Stein, Elliot A., Steins-Loeber, Sabine, Tapert, Susan F., Verdejo-Garcia, Antonio, Vollstaedt-Klein, Sabine, Wetherill, Reagan R., Wilson, Stephen J., Witkiewitz, Katie, Yuan, Kai, Zhang, Xiaochu, Zilverstand, Anna, Ekhtiari, Hamed, Zare-Bidoky, Mehran, Sangchooli, Arshiya, Janes, Amy C., Kaufman, Marc J., Oliver, Jason A., Prisciandaro, James J., Wustenberg, Torsten, Anton, Raymond F., Bach, Patrick, Baldacchino, Alex, Beck, Anne, Bjork, James M., Brewer, Judson, Childress, Anna Rose, Claus, Eric D., Courtney, Kelly E., Ebrahimi, Mohsen, Filbey, Francesca M., Ghahremani, Dara G., Azbari, Peyman Ghobadi, Goldstein, Rita Z., Goudriaan, Anna E., Grodin, Erica N., Hamilton, Paul, Hanlon, Colleen A., Hassani-Abharian, Peyman, Heinz, Andreas, Joseph, Jane E., Kiefer, Falk, Zonoozi, Arash Khojasteh, Kober, Hedy, Kuplicki, Rayus, Li, Qiang, London, Edythe D., McClernon, Joseph, Noori, Hamid R., Owens, Max M., Paulus, Martin, Perini, Irene, Potenza, Marc, Potvin, Stephane, Ray, Lara, Schacht, Joseph P., Seo, Dongju, Sinha, Rajita, Smolka, Michael N., Spanagel, Rainer, Steele, Vaughn R., Stein, Elliot A., Steins-Loeber, Sabine, Tapert, Susan F., Verdejo-Garcia, Antonio, Vollstaedt-Klein, Sabine, Wetherill, Reagan R., Wilson, Stephen J., Witkiewitz, Katie, Yuan, Kai, Zhang, Xiaochu, and Zilverstand, Anna
Abstract: Cue reactivity measured by functional magnetic resonance imaging is used in studies of substance-use disorders. This Consensus Statement is the result of a Delphi process to arrive at parameters that should be reported in describing these studies. Cue reactivity is one of the most frequently used paradigms in functional magnetic resonance imaging (fMRI) studies of substance use disorders (SUDs). Although there have been promising results elucidating the neurocognitive mechanisms of SUDs and SUD treatments, the interpretability and reproducibility of these studies is limited by incomplete reporting of participants characteristics, task design, craving assessment, scanning preparation and analysis decisions in fMRI drug cue reactivity (FDCR) experiments. This hampers clinical translation, not least because systematic review and meta-analysis of published work are difficult. This consensus paper and Delphi study aims to outline the important methodological aspects of FDCR research, present structured recommendations for more comprehensive methods reporting and review the FDCR literature to assess the reporting of items that are deemed important. Forty-five FDCR scientists from around the world participated in this study. First, an initial checklist of items deemed important in FDCR studies was developed by several members of the Enhanced NeuroImaging Genetics through Meta-Analyses (ENIGMA) Addiction working group on the basis of a systematic review. Using a modified Delphi consensus method, all experts were asked to comment on, revise or add items to the initial checklist, and then to rate the importance of each item in subsequent rounds. The reporting status of the items in the final checklist was investigated in 108 recently published FDCR studies identified through a systematic review. By the final round, 38 items reached the consensus threshold and were classified under seven major categories: Participants Characteristics, General fMRI Information, General Task Inf, Funding Agencies|National Institute on Alcohol Abuse and Alcoholism (NIAAA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [P50 AA010761]; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)German Research Foundation (DFG) [402170461-TRR 265, 40217046-TRR 265, 421888313, 437718741, 324164820]; DFGGerman Research Foundation (DFG)European Commission [402170461 - TRR 265]; California Tobacco-Related Disease Research Grant Program of the University of California [T30IP0962]; Laureate Institute for Brain Research (LIBR); Warren K. Family Foundation; Oklahoma Center for Advancement of Science and Technologies (OCAST) [HR18-139]; Brain and Behavior Foundation (NARSAD Young Investigator Award) [27305]; National Institute on Drug Abuse (NIDA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [R01 DA030344, R21DA044465]; NIDAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [R01DA041528, R01DA048301, R01DA047851, K23DA042898, K12 DA000167, U01 DA041089, U24 DA041147, P30 DA048742]; NCCIH [R01AT010627]; NIAAAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [F32AA027699, R01 AA027765, R01 AA026859, U01 AA021692, U24 AA021695, R01AA023665, R01AA022328]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01DA039135, K02DA042987, R01 DA041866, R01AA026844, K08AA023545, K23AA023894, R01DA040670, R21HL144673, R01DA041438, R21DA045853]; Bundesministerium fur Bildung und ForschungFederal Ministry of Education & Research (BMBF) [FKZ: 01ZX1503, 01ZX1909B]; Shanghai Municipal Science and Technology Major project [2019SHZ
Published: 2022
Full Text: View/download PDF

4. A methodological checklist for fMRI drug cue reactivity studies : development and expert consensus

Author: Ekhtiari, Hamed, Zare-Bidoky, Mehran, Sangchooli, Arshiya, Janes, Amy C., Kaufman, Marc J., Oliver, Jason A., Prisciandaro, James J., Wustenberg, Torsten, Anton, Raymond F., Bach, Patrick, Baldacchino, Alex, Beck, Anne, Bjork, James M., Brewer, Judson, Childress, Anna Rose, Claus, Eric D., Courtney, Kelly E., Ebrahimi, Mohsen, Filbey, Francesca M., Ghahremani, Dara G., Azbari, Peyman Ghobadi, Goldstein, Rita Z., Goudriaan, Anna E., Grodin, Erica N., Hamilton, Paul, Hanlon, Colleen A., Hassani-Abharian, Peyman, Heinz, Andreas, Joseph, Jane E., Kiefer, Falk, Zonoozi, Arash Khojasteh, Kober, Hedy, Kuplicki, Rayus, Li, Qiang, London, Edythe D., McClernon, Joseph, Noori, Hamid R., Owens, Max M., Paulus, Martin, Perini, Irene, Potenza, Marc, Potvin, Stephane, Ray, Lara, Schacht, Joseph P., Seo, Dongju, Sinha, Rajita, Smolka, Michael N., Spanagel, Rainer, Steele, Vaughn R., Stein, Elliot A., Steins-Loeber, Sabine, Tapert, Susan F., Verdejo-Garcia, Antonio, Vollstaedt-Klein, Sabine, Wetherill, Reagan R., Wilson, Stephen J., Witkiewitz, Katie, Yuan, Kai, Zhang, Xiaochu, Zilverstand, Anna, Ekhtiari, Hamed, Zare-Bidoky, Mehran, Sangchooli, Arshiya, Janes, Amy C., Kaufman, Marc J., Oliver, Jason A., Prisciandaro, James J., Wustenberg, Torsten, Anton, Raymond F., Bach, Patrick, Baldacchino, Alex, Beck, Anne, Bjork, James M., Brewer, Judson, Childress, Anna Rose, Claus, Eric D., Courtney, Kelly E., Ebrahimi, Mohsen, Filbey, Francesca M., Ghahremani, Dara G., Azbari, Peyman Ghobadi, Goldstein, Rita Z., Goudriaan, Anna E., Grodin, Erica N., Hamilton, Paul, Hanlon, Colleen A., Hassani-Abharian, Peyman, Heinz, Andreas, Joseph, Jane E., Kiefer, Falk, Zonoozi, Arash Khojasteh, Kober, Hedy, Kuplicki, Rayus, Li, Qiang, London, Edythe D., McClernon, Joseph, Noori, Hamid R., Owens, Max M., Paulus, Martin, Perini, Irene, Potenza, Marc, Potvin, Stephane, Ray, Lara, Schacht, Joseph P., Seo, Dongju, Sinha, Rajita, Smolka, Michael N., Spanagel, Rainer, Steele, Vaughn R., Stein, Elliot A., Steins-Loeber, Sabine, Tapert, Susan F., Verdejo-Garcia, Antonio, Vollstaedt-Klein, Sabine, Wetherill, Reagan R., Wilson, Stephen J., Witkiewitz, Katie, Yuan, Kai, Zhang, Xiaochu, and Zilverstand, Anna
Abstract: Cue reactivity measured by functional magnetic resonance imaging is used in studies of substance-use disorders. This Consensus Statement is the result of a Delphi process to arrive at parameters that should be reported in describing these studies. Cue reactivity is one of the most frequently used paradigms in functional magnetic resonance imaging (fMRI) studies of substance use disorders (SUDs). Although there have been promising results elucidating the neurocognitive mechanisms of SUDs and SUD treatments, the interpretability and reproducibility of these studies is limited by incomplete reporting of participants characteristics, task design, craving assessment, scanning preparation and analysis decisions in fMRI drug cue reactivity (FDCR) experiments. This hampers clinical translation, not least because systematic review and meta-analysis of published work are difficult. This consensus paper and Delphi study aims to outline the important methodological aspects of FDCR research, present structured recommendations for more comprehensive methods reporting and review the FDCR literature to assess the reporting of items that are deemed important. Forty-five FDCR scientists from around the world participated in this study. First, an initial checklist of items deemed important in FDCR studies was developed by several members of the Enhanced NeuroImaging Genetics through Meta-Analyses (ENIGMA) Addiction working group on the basis of a systematic review. Using a modified Delphi consensus method, all experts were asked to comment on, revise or add items to the initial checklist, and then to rate the importance of each item in subsequent rounds. The reporting status of the items in the final checklist was investigated in 108 recently published FDCR studies identified through a systematic review. By the final round, 38 items reached the consensus threshold and were classified under seven major categories: Participants Characteristics, General fMRI Information, General Task Inf, Funding Agencies|National Institute on Alcohol Abuse and Alcoholism (NIAAA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [P50 AA010761]; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)German Research Foundation (DFG) [402170461-TRR 265, 40217046-TRR 265, 421888313, 437718741, 324164820]; DFGGerman Research Foundation (DFG)European Commission [402170461 - TRR 265]; California Tobacco-Related Disease Research Grant Program of the University of California [T30IP0962]; Laureate Institute for Brain Research (LIBR); Warren K. Family Foundation; Oklahoma Center for Advancement of Science and Technologies (OCAST) [HR18-139]; Brain and Behavior Foundation (NARSAD Young Investigator Award) [27305]; National Institute on Drug Abuse (NIDA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [R01 DA030344, R21DA044465]; NIDAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [R01DA041528, R01DA048301, R01DA047851, K23DA042898, K12 DA000167, U01 DA041089, U24 DA041147, P30 DA048742]; NCCIH [R01AT010627]; NIAAAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [F32AA027699, R01 AA027765, R01 AA026859, U01 AA021692, U24 AA021695, R01AA023665, R01AA022328]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01DA039135, K02DA042987, R01 DA041866, R01AA026844, K08AA023545, K23AA023894, R01DA040670, R21HL144673, R01DA041438, R21DA045853]; Bundesministerium fur Bildung und ForschungFederal Ministry of Education & Research (BMBF) [FKZ: 01ZX1503, 01ZX1909B]; Shanghai Municipal Science and Technology Major project [2019SHZ
Published: 2022
Full Text: View/download PDF

5. White matter microstructure differences in individuals with dependence on cocaine, methamphetamine, and nicotine: Findings from the ENIGMA-Addiction working group.

Author: Ottino-González, Jonatan, Ottino-González, Jonatan, Uhlmann, Anne, Hahn, Sage, Cao, Zhipeng, Cupertino, Renata B, Schwab, Nathan, Allgaier, Nicholas, Alia-Klein, Nelly, Ekhtiari, Hamed, Fouche, Jean-Paul, Goldstein, Rita Z, Li, Chiang-Shan R, Lochner, Christine, London, Edythe D, Luijten, Maartje, Masjoodi, Sadegh, Momenan, Reza, Oghabian, Mohammad Ali, Roos, Annerine, Stein, Dan J, Stein, Elliot A, Veltman, Dick J, Verdejo-García, Antonio, Zhang, Sheng, Zhao, Min, Zhong, Na, Jahanshad, Neda, Thompson, Paul M, Conrod, Patricia, Mackey, Scott, Garavan, Hugh, Ottino-González, Jonatan, Ottino-González, Jonatan, Uhlmann, Anne, Hahn, Sage, Cao, Zhipeng, Cupertino, Renata B, Schwab, Nathan, Allgaier, Nicholas, Alia-Klein, Nelly, Ekhtiari, Hamed, Fouche, Jean-Paul, Goldstein, Rita Z, Li, Chiang-Shan R, Lochner, Christine, London, Edythe D, Luijten, Maartje, Masjoodi, Sadegh, Momenan, Reza, Oghabian, Mohammad Ali, Roos, Annerine, Stein, Dan J, Stein, Elliot A, Veltman, Dick J, Verdejo-García, Antonio, Zhang, Sheng, Zhao, Min, Zhong, Na, Jahanshad, Neda, Thompson, Paul M, Conrod, Patricia, Mackey, Scott, and Garavan, Hugh
Abstract: BackgroundNicotine and illicit stimulants are very addictive substances. Although associations between grey matter and dependence on stimulants have been frequently reported, white matter correlates have received less attention.MethodsEleven international sites ascribed to the ENIGMA-Addiction consortium contributed data from individuals with dependence on cocaine (n = 147), methamphetamine (n = 132) and nicotine (n = 189), as well as non-dependent controls (n = 333). We compared the fractional anisotropy (FA), axial diffusivity (AD), radial diffusivity (RD) and mean diffusivity (MD) of 20 bilateral tracts. Also, we compared the performance of various machine learning algorithms in deriving brain-based classifications on stimulant dependence.ResultsThe cocaine and methamphetamine groups had lower regional FA and higher RD in several association, commissural, and projection white matter tracts. The methamphetamine dependent group additionally showed lower regional AD. The nicotine group had lower FA and higher RD limited to the anterior limb of the internal capsule. The best performing machine learning algorithm was the support vector machine (SVM). The SVM successfully classified individuals with dependence on cocaine (AUC = 0.70, p < 0.001) and methamphetamine (AUC = 0.71, p < 0.001) relative to non-dependent controls. Classifications related to nicotine dependence proved modest (AUC = 0.62, p = 0.014).ConclusionsStimulant dependence was related to FA disturbances within tracts consistent with a role in addiction. The multivariate pattern of white matter differences proved sufficient to identify individuals with stimulant dependence, particularly for cocaine and methamphetamine.
Published: 2022

6. A methodological checklist for fMRI drug cue reactivity studies: development and expert consensus.

Author: Ekhtiari, Hamed, Ekhtiari, Hamed, Zare-Bidoky, Mehran, Sangchooli, Arshiya, Janes, Amy C, Kaufman, Marc J, Oliver, Jason A, Prisciandaro, James J, Wüstenberg, Torsten, Anton, Raymond F, Bach, Patrick, Baldacchino, Alex, Beck, Anne, Bjork, James M, Brewer, Judson, Childress, Anna Rose, Claus, Eric D, Courtney, Kelly E, Ebrahimi, Mohsen, Filbey, Francesca M, Ghahremani, Dara G, Azbari, Peyman Ghobadi, Goldstein, Rita Z, Goudriaan, Anna E, Grodin, Erica N, Hamilton, J Paul, Hanlon, Colleen A, Hassani-Abharian, Peyman, Heinz, Andreas, Joseph, Jane E, Kiefer, Falk, Zonoozi, Arash Khojasteh, Kober, Hedy, Kuplicki, Rayus, Li, Qiang, London, Edythe D, McClernon, Joseph, Noori, Hamid R, Owens, Max M, Paulus, Martin P, Perini, Irene, Potenza, Marc, Potvin, Stéphane, Ray, Lara, Schacht, Joseph P, Seo, Dongju, Sinha, Rajita, Smolka, Michael N, Spanagel, Rainer, Steele, Vaughn R, Stein, Elliot A, Steins-Loeber, Sabine, Tapert, Susan F, Verdejo-Garcia, Antonio, Vollstädt-Klein, Sabine, Wetherill, Reagan R, Wilson, Stephen J, Witkiewitz, Katie, Yuan, Kai, Zhang, Xiaochu, Zilverstand, Anna, Ekhtiari, Hamed, Ekhtiari, Hamed, Zare-Bidoky, Mehran, Sangchooli, Arshiya, Janes, Amy C, Kaufman, Marc J, Oliver, Jason A, Prisciandaro, James J, Wüstenberg, Torsten, Anton, Raymond F, Bach, Patrick, Baldacchino, Alex, Beck, Anne, Bjork, James M, Brewer, Judson, Childress, Anna Rose, Claus, Eric D, Courtney, Kelly E, Ebrahimi, Mohsen, Filbey, Francesca M, Ghahremani, Dara G, Azbari, Peyman Ghobadi, Goldstein, Rita Z, Goudriaan, Anna E, Grodin, Erica N, Hamilton, J Paul, Hanlon, Colleen A, Hassani-Abharian, Peyman, Heinz, Andreas, Joseph, Jane E, Kiefer, Falk, Zonoozi, Arash Khojasteh, Kober, Hedy, Kuplicki, Rayus, Li, Qiang, London, Edythe D, McClernon, Joseph, Noori, Hamid R, Owens, Max M, Paulus, Martin P, Perini, Irene, Potenza, Marc, Potvin, Stéphane, Ray, Lara, Schacht, Joseph P, Seo, Dongju, Sinha, Rajita, Smolka, Michael N, Spanagel, Rainer, Steele, Vaughn R, Stein, Elliot A, Steins-Loeber, Sabine, Tapert, Susan F, Verdejo-Garcia, Antonio, Vollstädt-Klein, Sabine, Wetherill, Reagan R, Wilson, Stephen J, Witkiewitz, Katie, Yuan, Kai, Zhang, Xiaochu, and Zilverstand, Anna
Abstract: Cue reactivity is one of the most frequently used paradigms in functional magnetic resonance imaging (fMRI) studies of substance use disorders (SUDs). Although there have been promising results elucidating the neurocognitive mechanisms of SUDs and SUD treatments, the interpretability and reproducibility of these studies is limited by incomplete reporting of participants' characteristics, task design, craving assessment, scanning preparation and analysis decisions in fMRI drug cue reactivity (FDCR) experiments. This hampers clinical translation, not least because systematic review and meta-analysis of published work are difficult. This consensus paper and Delphi study aims to outline the important methodological aspects of FDCR research, present structured recommendations for more comprehensive methods reporting and review the FDCR literature to assess the reporting of items that are deemed important. Forty-five FDCR scientists from around the world participated in this study. First, an initial checklist of items deemed important in FDCR studies was developed by several members of the Enhanced NeuroImaging Genetics through Meta-Analyses (ENIGMA) Addiction working group on the basis of a systematic review. Using a modified Delphi consensus method, all experts were asked to comment on, revise or add items to the initial checklist, and then to rate the importance of each item in subsequent rounds. The reporting status of the items in the final checklist was investigated in 108 recently published FDCR studies identified through a systematic review. By the final round, 38 items reached the consensus threshold and were classified under seven major categories: 'Participants' Characteristics', 'General fMRI Information', 'General Task Information', 'Cue Information', 'Craving Assessment Inside Scanner', 'Craving Assessment Outside Scanner' and 'Pre- and Post-Scanning Considerations'. The review of the 108 FDCR papers revealed significant gaps in the reporting of the items co
Published: 2022

7. A methodological checklist for fMRI drug cue reactivity studies : development and expert consensus

Author: Ekhtiari, Hamed, Zare-Bidoky, Mehran, Sangchooli, Arshiya, Janes, Amy C., Kaufman, Marc J., Oliver, Jason A., Prisciandaro, James J., Wustenberg, Torsten, Anton, Raymond F., Bach, Patrick, Baldacchino, Alex, Beck, Anne, Bjork, James M., Brewer, Judson, Childress, Anna Rose, Claus, Eric D., Courtney, Kelly E., Ebrahimi, Mohsen, Filbey, Francesca M., Ghahremani, Dara G., Azbari, Peyman Ghobadi, Goldstein, Rita Z., Goudriaan, Anna E., Grodin, Erica N., Hamilton, Paul, Hanlon, Colleen A., Hassani-Abharian, Peyman, Heinz, Andreas, Joseph, Jane E., Kiefer, Falk, Zonoozi, Arash Khojasteh, Kober, Hedy, Kuplicki, Rayus, Li, Qiang, London, Edythe D., McClernon, Joseph, Noori, Hamid R., Owens, Max M., Paulus, Martin, Perini, Irene, Potenza, Marc, Potvin, Stephane, Ray, Lara, Schacht, Joseph P., Seo, Dongju, Sinha, Rajita, Smolka, Michael N., Spanagel, Rainer, Steele, Vaughn R., Stein, Elliot A., Steins-Loeber, Sabine, Tapert, Susan F., Verdejo-Garcia, Antonio, Vollstaedt-Klein, Sabine, Wetherill, Reagan R., Wilson, Stephen J., Witkiewitz, Katie, Yuan, Kai, Zhang, Xiaochu, Zilverstand, Anna, Ekhtiari, Hamed, Zare-Bidoky, Mehran, Sangchooli, Arshiya, Janes, Amy C., Kaufman, Marc J., Oliver, Jason A., Prisciandaro, James J., Wustenberg, Torsten, Anton, Raymond F., Bach, Patrick, Baldacchino, Alex, Beck, Anne, Bjork, James M., Brewer, Judson, Childress, Anna Rose, Claus, Eric D., Courtney, Kelly E., Ebrahimi, Mohsen, Filbey, Francesca M., Ghahremani, Dara G., Azbari, Peyman Ghobadi, Goldstein, Rita Z., Goudriaan, Anna E., Grodin, Erica N., Hamilton, Paul, Hanlon, Colleen A., Hassani-Abharian, Peyman, Heinz, Andreas, Joseph, Jane E., Kiefer, Falk, Zonoozi, Arash Khojasteh, Kober, Hedy, Kuplicki, Rayus, Li, Qiang, London, Edythe D., McClernon, Joseph, Noori, Hamid R., Owens, Max M., Paulus, Martin, Perini, Irene, Potenza, Marc, Potvin, Stephane, Ray, Lara, Schacht, Joseph P., Seo, Dongju, Sinha, Rajita, Smolka, Michael N., Spanagel, Rainer, Steele, Vaughn R., Stein, Elliot A., Steins-Loeber, Sabine, Tapert, Susan F., Verdejo-Garcia, Antonio, Vollstaedt-Klein, Sabine, Wetherill, Reagan R., Wilson, Stephen J., Witkiewitz, Katie, Yuan, Kai, Zhang, Xiaochu, and Zilverstand, Anna
Abstract: Cue reactivity measured by functional magnetic resonance imaging is used in studies of substance-use disorders. This Consensus Statement is the result of a Delphi process to arrive at parameters that should be reported in describing these studies. Cue reactivity is one of the most frequently used paradigms in functional magnetic resonance imaging (fMRI) studies of substance use disorders (SUDs). Although there have been promising results elucidating the neurocognitive mechanisms of SUDs and SUD treatments, the interpretability and reproducibility of these studies is limited by incomplete reporting of participants characteristics, task design, craving assessment, scanning preparation and analysis decisions in fMRI drug cue reactivity (FDCR) experiments. This hampers clinical translation, not least because systematic review and meta-analysis of published work are difficult. This consensus paper and Delphi study aims to outline the important methodological aspects of FDCR research, present structured recommendations for more comprehensive methods reporting and review the FDCR literature to assess the reporting of items that are deemed important. Forty-five FDCR scientists from around the world participated in this study. First, an initial checklist of items deemed important in FDCR studies was developed by several members of the Enhanced NeuroImaging Genetics through Meta-Analyses (ENIGMA) Addiction working group on the basis of a systematic review. Using a modified Delphi consensus method, all experts were asked to comment on, revise or add items to the initial checklist, and then to rate the importance of each item in subsequent rounds. The reporting status of the items in the final checklist was investigated in 108 recently published FDCR studies identified through a systematic review. By the final round, 38 items reached the consensus threshold and were classified under seven major categories: Participants Characteristics, General fMRI Information, General Task Inf, Funding Agencies|National Institute on Alcohol Abuse and Alcoholism (NIAAA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [P50 AA010761]; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)German Research Foundation (DFG) [402170461-TRR 265, 40217046-TRR 265, 421888313, 437718741, 324164820]; DFGGerman Research Foundation (DFG)European Commission [402170461 - TRR 265]; California Tobacco-Related Disease Research Grant Program of the University of California [T30IP0962]; Laureate Institute for Brain Research (LIBR); Warren K. Family Foundation; Oklahoma Center for Advancement of Science and Technologies (OCAST) [HR18-139]; Brain and Behavior Foundation (NARSAD Young Investigator Award) [27305]; National Institute on Drug Abuse (NIDA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [R01 DA030344, R21DA044465]; NIDAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [R01DA041528, R01DA048301, R01DA047851, K23DA042898, K12 DA000167, U01 DA041089, U24 DA041147, P30 DA048742]; NCCIH [R01AT010627]; NIAAAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [F32AA027699, R01 AA027765, R01 AA026859, U01 AA021692, U24 AA021695, R01AA023665, R01AA022328]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01DA039135, K02DA042987, R01 DA041866, R01AA026844, K08AA023545, K23AA023894, R01DA040670, R21HL144673, R01DA041438, R21DA045853]; Bundesministerium fur Bildung und ForschungFederal Ministry of Education & Research (BMBF) [FKZ: 01ZX1503, 01ZX1909B]; Shanghai Municipal Science and Technology Major project [2019SHZ
Published: 2022
Full Text: View/download PDF

8. A methodological checklist for fMRI drug cue reactivity studies : development and expert consensus

Author: Ekhtiari, Hamed, Zare-Bidoky, Mehran, Sangchooli, Arshiya, Janes, Amy C., Kaufman, Marc J., Oliver, Jason A., Prisciandaro, James J., Wustenberg, Torsten, Anton, Raymond F., Bach, Patrick, Baldacchino, Alex, Beck, Anne, Bjork, James M., Brewer, Judson, Childress, Anna Rose, Claus, Eric D., Courtney, Kelly E., Ebrahimi, Mohsen, Filbey, Francesca M., Ghahremani, Dara G., Azbari, Peyman Ghobadi, Goldstein, Rita Z., Goudriaan, Anna E., Grodin, Erica N., Hamilton, Paul, Hanlon, Colleen A., Hassani-Abharian, Peyman, Heinz, Andreas, Joseph, Jane E., Kiefer, Falk, Zonoozi, Arash Khojasteh, Kober, Hedy, Kuplicki, Rayus, Li, Qiang, London, Edythe D., McClernon, Joseph, Noori, Hamid R., Owens, Max M., Paulus, Martin, Perini, Irene, Potenza, Marc, Potvin, Stephane, Ray, Lara, Schacht, Joseph P., Seo, Dongju, Sinha, Rajita, Smolka, Michael N., Spanagel, Rainer, Steele, Vaughn R., Stein, Elliot A., Steins-Loeber, Sabine, Tapert, Susan F., Verdejo-Garcia, Antonio, Vollstaedt-Klein, Sabine, Wetherill, Reagan R., Wilson, Stephen J., Witkiewitz, Katie, Yuan, Kai, Zhang, Xiaochu, Zilverstand, Anna, Ekhtiari, Hamed, Zare-Bidoky, Mehran, Sangchooli, Arshiya, Janes, Amy C., Kaufman, Marc J., Oliver, Jason A., Prisciandaro, James J., Wustenberg, Torsten, Anton, Raymond F., Bach, Patrick, Baldacchino, Alex, Beck, Anne, Bjork, James M., Brewer, Judson, Childress, Anna Rose, Claus, Eric D., Courtney, Kelly E., Ebrahimi, Mohsen, Filbey, Francesca M., Ghahremani, Dara G., Azbari, Peyman Ghobadi, Goldstein, Rita Z., Goudriaan, Anna E., Grodin, Erica N., Hamilton, Paul, Hanlon, Colleen A., Hassani-Abharian, Peyman, Heinz, Andreas, Joseph, Jane E., Kiefer, Falk, Zonoozi, Arash Khojasteh, Kober, Hedy, Kuplicki, Rayus, Li, Qiang, London, Edythe D., McClernon, Joseph, Noori, Hamid R., Owens, Max M., Paulus, Martin, Perini, Irene, Potenza, Marc, Potvin, Stephane, Ray, Lara, Schacht, Joseph P., Seo, Dongju, Sinha, Rajita, Smolka, Michael N., Spanagel, Rainer, Steele, Vaughn R., Stein, Elliot A., Steins-Loeber, Sabine, Tapert, Susan F., Verdejo-Garcia, Antonio, Vollstaedt-Klein, Sabine, Wetherill, Reagan R., Wilson, Stephen J., Witkiewitz, Katie, Yuan, Kai, Zhang, Xiaochu, and Zilverstand, Anna
Abstract: Cue reactivity measured by functional magnetic resonance imaging is used in studies of substance-use disorders. This Consensus Statement is the result of a Delphi process to arrive at parameters that should be reported in describing these studies. Cue reactivity is one of the most frequently used paradigms in functional magnetic resonance imaging (fMRI) studies of substance use disorders (SUDs). Although there have been promising results elucidating the neurocognitive mechanisms of SUDs and SUD treatments, the interpretability and reproducibility of these studies is limited by incomplete reporting of participants characteristics, task design, craving assessment, scanning preparation and analysis decisions in fMRI drug cue reactivity (FDCR) experiments. This hampers clinical translation, not least because systematic review and meta-analysis of published work are difficult. This consensus paper and Delphi study aims to outline the important methodological aspects of FDCR research, present structured recommendations for more comprehensive methods reporting and review the FDCR literature to assess the reporting of items that are deemed important. Forty-five FDCR scientists from around the world participated in this study. First, an initial checklist of items deemed important in FDCR studies was developed by several members of the Enhanced NeuroImaging Genetics through Meta-Analyses (ENIGMA) Addiction working group on the basis of a systematic review. Using a modified Delphi consensus method, all experts were asked to comment on, revise or add items to the initial checklist, and then to rate the importance of each item in subsequent rounds. The reporting status of the items in the final checklist was investigated in 108 recently published FDCR studies identified through a systematic review. By the final round, 38 items reached the consensus threshold and were classified under seven major categories: Participants Characteristics, General fMRI Information, General Task Inf, Funding Agencies|National Institute on Alcohol Abuse and Alcoholism (NIAAA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [P50 AA010761]; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)German Research Foundation (DFG) [402170461-TRR 265, 40217046-TRR 265, 421888313, 437718741, 324164820]; DFGGerman Research Foundation (DFG)European Commission [402170461 - TRR 265]; California Tobacco-Related Disease Research Grant Program of the University of California [T30IP0962]; Laureate Institute for Brain Research (LIBR); Warren K. Family Foundation; Oklahoma Center for Advancement of Science and Technologies (OCAST) [HR18-139]; Brain and Behavior Foundation (NARSAD Young Investigator Award) [27305]; National Institute on Drug Abuse (NIDA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [R01 DA030344, R21DA044465]; NIDAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [R01DA041528, R01DA048301, R01DA047851, K23DA042898, K12 DA000167, U01 DA041089, U24 DA041147, P30 DA048742]; NCCIH [R01AT010627]; NIAAAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [F32AA027699, R01 AA027765, R01 AA026859, U01 AA021692, U24 AA021695, R01AA023665, R01AA022328]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01DA039135, K02DA042987, R01 DA041866, R01AA026844, K08AA023545, K23AA023894, R01DA040670, R21HL144673, R01DA041438, R21DA045853]; Bundesministerium fur Bildung und ForschungFederal Ministry of Education & Research (BMBF) [FKZ: 01ZX1503, 01ZX1909B]; Shanghai Municipal Science and Technology Major project [2019SHZ
Published: 2022
Full Text: View/download PDF

9. A methodological checklist for fMRI drug cue reactivity studies : development and expert consensus

Author: Ekhtiari, Hamed, Zare-Bidoky, Mehran, Sangchooli, Arshiya, Janes, Amy C., Kaufman, Marc J., Oliver, Jason A., Prisciandaro, James J., Wustenberg, Torsten, Anton, Raymond F., Bach, Patrick, Baldacchino, Alex, Beck, Anne, Bjork, James M., Brewer, Judson, Childress, Anna Rose, Claus, Eric D., Courtney, Kelly E., Ebrahimi, Mohsen, Filbey, Francesca M., Ghahremani, Dara G., Azbari, Peyman Ghobadi, Goldstein, Rita Z., Goudriaan, Anna E., Grodin, Erica N., Hamilton, Paul, Hanlon, Colleen A., Hassani-Abharian, Peyman, Heinz, Andreas, Joseph, Jane E., Kiefer, Falk, Zonoozi, Arash Khojasteh, Kober, Hedy, Kuplicki, Rayus, Li, Qiang, London, Edythe D., McClernon, Joseph, Noori, Hamid R., Owens, Max M., Paulus, Martin, Perini, Irene, Potenza, Marc, Potvin, Stephane, Ray, Lara, Schacht, Joseph P., Seo, Dongju, Sinha, Rajita, Smolka, Michael N., Spanagel, Rainer, Steele, Vaughn R., Stein, Elliot A., Steins-Loeber, Sabine, Tapert, Susan F., Verdejo-Garcia, Antonio, Vollstaedt-Klein, Sabine, Wetherill, Reagan R., Wilson, Stephen J., Witkiewitz, Katie, Yuan, Kai, Zhang, Xiaochu, Zilverstand, Anna, Ekhtiari, Hamed, Zare-Bidoky, Mehran, Sangchooli, Arshiya, Janes, Amy C., Kaufman, Marc J., Oliver, Jason A., Prisciandaro, James J., Wustenberg, Torsten, Anton, Raymond F., Bach, Patrick, Baldacchino, Alex, Beck, Anne, Bjork, James M., Brewer, Judson, Childress, Anna Rose, Claus, Eric D., Courtney, Kelly E., Ebrahimi, Mohsen, Filbey, Francesca M., Ghahremani, Dara G., Azbari, Peyman Ghobadi, Goldstein, Rita Z., Goudriaan, Anna E., Grodin, Erica N., Hamilton, Paul, Hanlon, Colleen A., Hassani-Abharian, Peyman, Heinz, Andreas, Joseph, Jane E., Kiefer, Falk, Zonoozi, Arash Khojasteh, Kober, Hedy, Kuplicki, Rayus, Li, Qiang, London, Edythe D., McClernon, Joseph, Noori, Hamid R., Owens, Max M., Paulus, Martin, Perini, Irene, Potenza, Marc, Potvin, Stephane, Ray, Lara, Schacht, Joseph P., Seo, Dongju, Sinha, Rajita, Smolka, Michael N., Spanagel, Rainer, Steele, Vaughn R., Stein, Elliot A., Steins-Loeber, Sabine, Tapert, Susan F., Verdejo-Garcia, Antonio, Vollstaedt-Klein, Sabine, Wetherill, Reagan R., Wilson, Stephen J., Witkiewitz, Katie, Yuan, Kai, Zhang, Xiaochu, and Zilverstand, Anna
Abstract: Cue reactivity measured by functional magnetic resonance imaging is used in studies of substance-use disorders. This Consensus Statement is the result of a Delphi process to arrive at parameters that should be reported in describing these studies. Cue reactivity is one of the most frequently used paradigms in functional magnetic resonance imaging (fMRI) studies of substance use disorders (SUDs). Although there have been promising results elucidating the neurocognitive mechanisms of SUDs and SUD treatments, the interpretability and reproducibility of these studies is limited by incomplete reporting of participants characteristics, task design, craving assessment, scanning preparation and analysis decisions in fMRI drug cue reactivity (FDCR) experiments. This hampers clinical translation, not least because systematic review and meta-analysis of published work are difficult. This consensus paper and Delphi study aims to outline the important methodological aspects of FDCR research, present structured recommendations for more comprehensive methods reporting and review the FDCR literature to assess the reporting of items that are deemed important. Forty-five FDCR scientists from around the world participated in this study. First, an initial checklist of items deemed important in FDCR studies was developed by several members of the Enhanced NeuroImaging Genetics through Meta-Analyses (ENIGMA) Addiction working group on the basis of a systematic review. Using a modified Delphi consensus method, all experts were asked to comment on, revise or add items to the initial checklist, and then to rate the importance of each item in subsequent rounds. The reporting status of the items in the final checklist was investigated in 108 recently published FDCR studies identified through a systematic review. By the final round, 38 items reached the consensus threshold and were classified under seven major categories: Participants Characteristics, General fMRI Information, General Task Inf, Funding Agencies|National Institute on Alcohol Abuse and Alcoholism (NIAAA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [P50 AA010761]; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)German Research Foundation (DFG) [402170461-TRR 265, 40217046-TRR 265, 421888313, 437718741, 324164820]; DFGGerman Research Foundation (DFG)European Commission [402170461 - TRR 265]; California Tobacco-Related Disease Research Grant Program of the University of California [T30IP0962]; Laureate Institute for Brain Research (LIBR); Warren K. Family Foundation; Oklahoma Center for Advancement of Science and Technologies (OCAST) [HR18-139]; Brain and Behavior Foundation (NARSAD Young Investigator Award) [27305]; National Institute on Drug Abuse (NIDA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [R01 DA030344, R21DA044465]; NIDAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [R01DA041528, R01DA048301, R01DA047851, K23DA042898, K12 DA000167, U01 DA041089, U24 DA041147, P30 DA048742]; NCCIH [R01AT010627]; NIAAAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [F32AA027699, R01 AA027765, R01 AA026859, U01 AA021692, U24 AA021695, R01AA023665, R01AA022328]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01DA039135, K02DA042987, R01 DA041866, R01AA026844, K08AA023545, K23AA023894, R01DA040670, R21HL144673, R01DA041438, R21DA045853]; Bundesministerium fur Bildung und ForschungFederal Ministry of Education & Research (BMBF) [FKZ: 01ZX1503, 01ZX1909B]; Shanghai Municipal Science and Technology Major project [2019SHZ
Published: 2022
Full Text: View/download PDF

10. Self-awareness of problematic drug use: Preliminary validation of a new fMRI task to assess underlying neurocircuitry.

Author: Moeller, Scott J, Moeller, Scott J, Kundu, Prantik, Bachi, Keren, Maloney, Thomas, Malaker, Pias, Parvaz, Muhammad A, Alia-Klein, Nelly, London, Edythe D, Goldstein, Rita Z, Moeller, Scott J, Moeller, Scott J, Kundu, Prantik, Bachi, Keren, Maloney, Thomas, Malaker, Pias, Parvaz, Muhammad A, Alia-Klein, Nelly, London, Edythe D, and Goldstein, Rita Z
Abstract: BackgroundMultiple psychopathologies feature impaired clinical insight. Emerging evidence suggests that insight problems may similarly characterize addiction, perhaps due to aberrant functioning of self-referential brain circuitry, including the rostral anterior cingulate and ventromedial prefrontal cortices (rACC/vmPFC). We developed a new fMRI task to probe whether rACC/vmPFC abnormalities in cocaine use disorder (CUD) constitute neural correlates of readiness to change, one facet of insight.MethodsEighteen individuals with current CUD and 15 healthy controls responded about their own need to change their drug use and eating behavior (control condition) and the need for a named acquaintance to do the same (two additional control conditions). Measures of simulated drug-choice behavior, addiction severity, and neuropsychological function were collected outside the scanner.ResultsCUD participants perceived a greater need for behavior change than controls (as expected, given their diagnosis), but fell short of "agreeing" to a need for change; in CUD, lower perceived need correlated with higher simulated drug-choice behavior, a proxy measure of drug-seeking. During drug-related insight judgments, CUD participants had higher activation than controls in an anatomically-defined region of interest (ROI) in the medial orbitofrontal cortex, part of the rACC/vmPFC. Although not showing group differences, activation in an anatomically-defined ACC ROI correlated with insight-related task behavior (in all participants) and memory performance (in CUD).ConclusionsAs a group, individuals with current CUD appear to show mild insight problems and rACC/vmPFC abnormalities vis-à-vis readiness to change behavior. With replication and extension of these results, insight-related circuitry may emerge as a novel therapeutic target.
Published: 2020

11. Self-awareness of problematic drug use: Preliminary validation of a new fMRI task to assess underlying neurocircuitry.

Author: Moeller, Scott J, Moeller, Scott J, Kundu, Prantik, Bachi, Keren, Maloney, Thomas, Malaker, Pias, Parvaz, Muhammad A, Alia-Klein, Nelly, London, Edythe D, Goldstein, Rita Z, Moeller, Scott J, Moeller, Scott J, Kundu, Prantik, Bachi, Keren, Maloney, Thomas, Malaker, Pias, Parvaz, Muhammad A, Alia-Klein, Nelly, London, Edythe D, and Goldstein, Rita Z
Abstract: BackgroundMultiple psychopathologies feature impaired clinical insight. Emerging evidence suggests that insight problems may similarly characterize addiction, perhaps due to aberrant functioning of self-referential brain circuitry, including the rostral anterior cingulate and ventromedial prefrontal cortices (rACC/vmPFC). We developed a new fMRI task to probe whether rACC/vmPFC abnormalities in cocaine use disorder (CUD) constitute neural correlates of readiness to change, one facet of insight.MethodsEighteen individuals with current CUD and 15 healthy controls responded about their own need to change their drug use and eating behavior (control condition) and the need for a named acquaintance to do the same (two additional control conditions). Measures of simulated drug-choice behavior, addiction severity, and neuropsychological function were collected outside the scanner.ResultsCUD participants perceived a greater need for behavior change than controls (as expected, given their diagnosis), but fell short of "agreeing" to a need for change; in CUD, lower perceived need correlated with higher simulated drug-choice behavior, a proxy measure of drug-seeking. During drug-related insight judgments, CUD participants had higher activation than controls in an anatomically-defined region of interest (ROI) in the medial orbitofrontal cortex, part of the rACC/vmPFC. Although not showing group differences, activation in an anatomically-defined ACC ROI correlated with insight-related task behavior (in all participants) and memory performance (in CUD).ConclusionsAs a group, individuals with current CUD appear to show mild insight problems and rACC/vmPFC abnormalities vis-à-vis readiness to change behavior. With replication and extension of these results, insight-related circuitry may emerge as a novel therapeutic target.
Published: 2020

12. A transdiagnostic dimensional approach towards a neuropsychological assessment for addiction: an international Delphi consensus study.

Author: Yucel, Murat, Oldenhof, Erin, Ahmed, Serge, Belin, David, Billieux, Joël, Bowden-Jones, Henrietta, Carter, Adrian, Chamberlain, Samuel R., Clark, Luke, Connor, Jason, Daglish, Mark, Dom, Geert, Dannon, Pinhas, Duka, Theodora, Fernandez-Serrano, Maria Jose, Field, Matt, Franken, Ingmar, Goldstein, Rita Z., Gonzalez, Raul, Goudriaan, Anneke, Grant, Jon E., Gullo, Matthew J., Hester, Rob, Hodgins, David, Le Foll, Bernard, Lee, Rico S. C., Lingford-Hughes, Anne, Lorenzetti, Valentina, Moeller, Scott J., Munafo, Marcus R., Odlaug, Brian, Potenza, Marc N., Segrave, Rebecca, Sjoerds, Zsuzsika, Solowij, Nadia, van den Brink, Wim, Van Holst, Ruth J., Voon, Valerie, Wiers, Reinout, Fontenelle, Leonardo F., Verdejo-Garcia, Antonio, Yucel, Murat, Oldenhof, Erin, Ahmed, Serge, Belin, David, Billieux, Joël, Bowden-Jones, Henrietta, Carter, Adrian, Chamberlain, Samuel R., Clark, Luke, Connor, Jason, Daglish, Mark, Dom, Geert, Dannon, Pinhas, Duka, Theodora, Fernandez-Serrano, Maria Jose, Field, Matt, Franken, Ingmar, Goldstein, Rita Z., Gonzalez, Raul, Goudriaan, Anneke, Grant, Jon E., Gullo, Matthew J., Hester, Rob, Hodgins, David, Le Foll, Bernard, Lee, Rico S. C., Lingford-Hughes, Anne, Lorenzetti, Valentina, Moeller, Scott J., Munafo, Marcus R., Odlaug, Brian, Potenza, Marc N., Segrave, Rebecca, Sjoerds, Zsuzsika, Solowij, Nadia, van den Brink, Wim, Van Holst, Ruth J., Voon, Valerie, Wiers, Reinout, Fontenelle, Leonardo F., and Verdejo-Garcia, Antonio
Abstract: BACKGROUND: The U.S. National Institutes of Mental Health Research Domain Criteria (RDoC) seek to stimulate research into biologically validated neuropsychological dimensions across mental illness symptoms and diagnoses. The RDoC framework comprises 39 functional constructs designed to be revised and refined, with the overall goal to improve diagnostic validity and treatments. This study aimed to reach a consensus among experts in the addiction field on the 'primary' RDoC constructs most relevant to substance and behavioural addictions. METHODS: Forty-four addiction experts were recruited from Australia, Asia, Europe and the Americas. The Delphi technique was used to determine a consensus as to the degree of importance of each construct in understanding the essential dimensions underpinning addictive behaviours. Expert opinions were canvassed online over three rounds (97% completion rate), with each consecutive round offering feedback for experts to review their opinions. RESULTS: Seven constructs were endorsed by >/=80% of experts as 'primary' to the understanding of addictive behaviour: five from the Positive Valence System (Reward Valuation, Expectancy, Action Selection, Reward Learning, Habit); one from the Cognitive Control System (Response Selection/Inhibition); and one expert-initiated construct (Compulsivity). These constructs were rated to be differentially related to stages of the addiction cycle, with some more closely linked to addiction onset, and others more to chronicity. Experts agreed that these neuropsychological dimensions apply across a range of addictions. CONCLUSIONS: The study offers a novel and neuropsychologically informed theoretical framework, as well as a cogent step forward to test transdiagnostic concepts in addiction research, with direct implications for assessment, diagnosis, staging of disorder, and treatment.
Published: 2019

13. A transdiagnostic dimensional approach towards a neuropsychological assessment for addiction: an international Delphi consensus study.

Author: Yucel, Murat, Oldenhof, Erin, Ahmed, Serge, Belin, David, Billieux, Joël, Bowden-Jones, Henrietta, Carter, Adrian, Chamberlain, Samuel R., Clark, Luke, Connor, Jason, Daglish, Mark, Dom, Geert, Dannon, Pinhas, Duka, Theodora, Fernandez-Serrano, Maria Jose, Field, Matt, Franken, Ingmar, Goldstein, Rita Z., Gonzalez, Raul, Goudriaan, Anneke, Grant, Jon E., Gullo, Matthew J., Hester, Rob, Hodgins, David, Le Foll, Bernard, Lee, Rico S. C., Lingford-Hughes, Anne, Lorenzetti, Valentina, Moeller, Scott J., Munafo, Marcus R., Odlaug, Brian, Potenza, Marc N., Segrave, Rebecca, Sjoerds, Zsuzsika, Solowij, Nadia, van den Brink, Wim, Van Holst, Ruth J., Voon, Valerie, Wiers, Reinout, Fontenelle, Leonardo F., Verdejo-Garcia, Antonio, Yucel, Murat, Oldenhof, Erin, Ahmed, Serge, Belin, David, Billieux, Joël, Bowden-Jones, Henrietta, Carter, Adrian, Chamberlain, Samuel R., Clark, Luke, Connor, Jason, Daglish, Mark, Dom, Geert, Dannon, Pinhas, Duka, Theodora, Fernandez-Serrano, Maria Jose, Field, Matt, Franken, Ingmar, Goldstein, Rita Z., Gonzalez, Raul, Goudriaan, Anneke, Grant, Jon E., Gullo, Matthew J., Hester, Rob, Hodgins, David, Le Foll, Bernard, Lee, Rico S. C., Lingford-Hughes, Anne, Lorenzetti, Valentina, Moeller, Scott J., Munafo, Marcus R., Odlaug, Brian, Potenza, Marc N., Segrave, Rebecca, Sjoerds, Zsuzsika, Solowij, Nadia, van den Brink, Wim, Van Holst, Ruth J., Voon, Valerie, Wiers, Reinout, Fontenelle, Leonardo F., and Verdejo-Garcia, Antonio
Abstract: BACKGROUND: The U.S. National Institutes of Mental Health Research Domain Criteria (RDoC) seek to stimulate research into biologically validated neuropsychological dimensions across mental illness symptoms and diagnoses. The RDoC framework comprises 39 functional constructs designed to be revised and refined, with the overall goal to improve diagnostic validity and treatments. This study aimed to reach a consensus among experts in the addiction field on the 'primary' RDoC constructs most relevant to substance and behavioural addictions. METHODS: Forty-four addiction experts were recruited from Australia, Asia, Europe and the Americas. The Delphi technique was used to determine a consensus as to the degree of importance of each construct in understanding the essential dimensions underpinning addictive behaviours. Expert opinions were canvassed online over three rounds (97% completion rate), with each consecutive round offering feedback for experts to review their opinions. RESULTS: Seven constructs were endorsed by >/=80% of experts as 'primary' to the understanding of addictive behaviour: five from the Positive Valence System (Reward Valuation, Expectancy, Action Selection, Reward Learning, Habit); one from the Cognitive Control System (Response Selection/Inhibition); and one expert-initiated construct (Compulsivity). These constructs were rated to be differentially related to stages of the addiction cycle, with some more closely linked to addiction onset, and others more to chronicity. Experts agreed that these neuropsychological dimensions apply across a range of addictions. CONCLUSIONS: The study offers a novel and neuropsychologically informed theoretical framework, as well as a cogent step forward to test transdiagnostic concepts in addiction research, with direct implications for assessment, diagnosis, staging of disorder, and treatment.
Published: 2019

14. Mega-Analysis of Gray Matter Volume in Substance Dependence: General and Substance-Specific Regional Effects.

Author: Mackey, Scott, Mackey, Scott, Allgaier, Nicholas, Chaarani, Bader, Spechler, Philip, Orr, Catherine, Bunn, Janice, Allen, Nicholas B, Alia-Klein, Nelly, Batalla, Albert, Blaine, Sara, Brooks, Samantha, Caparelli, Elisabeth, Chye, Yann Ying, Cousijn, Janna, Dagher, Alain, Desrivieres, Sylvane, Feldstein-Ewing, Sarah, Foxe, John J, Goldstein, Rita Z, Goudriaan, Anna E, Heitzeg, Mary M, Hester, Robert, Hutchison, Kent, Korucuoglu, Ozlem, Li, Chiang-Shan R, London, Edythe, Lorenzetti, Valentina, Luijten, Maartje, Martin-Santos, Rocio, May, April, Momenan, Reza, Morales, Angelica, Paulus, Martin P, Pearlson, Godfrey, Rousseau, Marc-Etienne, Salmeron, Betty Jo, Schluter, Renée, Schmaal, Lianne, Schumann, Gunter, Sjoerds, Zsuzsika, Stein, Dan J, Stein, Elliot A, Sinha, Rajita, Solowij, Nadia, Tapert, Susan, Uhlmann, Anne, Veltman, Dick, van Holst, Ruth, Whittle, Sarah, Wright, Margaret J, Yücel, Murat, Zhang, Sheng, Yurgelun-Todd, Deborah, Hibar, Derrek P, Jahanshad, Neda, Evans, Alan, Thompson, Paul M, Glahn, David C, Conrod, Patricia, Garavan, Hugh, ENIGMA Addiction Working Group, Mackey, Scott, Mackey, Scott, Allgaier, Nicholas, Chaarani, Bader, Spechler, Philip, Orr, Catherine, Bunn, Janice, Allen, Nicholas B, Alia-Klein, Nelly, Batalla, Albert, Blaine, Sara, Brooks, Samantha, Caparelli, Elisabeth, Chye, Yann Ying, Cousijn, Janna, Dagher, Alain, Desrivieres, Sylvane, Feldstein-Ewing, Sarah, Foxe, John J, Goldstein, Rita Z, Goudriaan, Anna E, Heitzeg, Mary M, Hester, Robert, Hutchison, Kent, Korucuoglu, Ozlem, Li, Chiang-Shan R, London, Edythe, Lorenzetti, Valentina, Luijten, Maartje, Martin-Santos, Rocio, May, April, Momenan, Reza, Morales, Angelica, Paulus, Martin P, Pearlson, Godfrey, Rousseau, Marc-Etienne, Salmeron, Betty Jo, Schluter, Renée, Schmaal, Lianne, Schumann, Gunter, Sjoerds, Zsuzsika, Stein, Dan J, Stein, Elliot A, Sinha, Rajita, Solowij, Nadia, Tapert, Susan, Uhlmann, Anne, Veltman, Dick, van Holst, Ruth, Whittle, Sarah, Wright, Margaret J, Yücel, Murat, Zhang, Sheng, Yurgelun-Todd, Deborah, Hibar, Derrek P, Jahanshad, Neda, Evans, Alan, Thompson, Paul M, Glahn, David C, Conrod, Patricia, Garavan, Hugh, and ENIGMA Addiction Working Group
Abstract: ObjectiveAlthough lower brain volume has been routinely observed in individuals with substance dependence compared with nondependent control subjects, the brain regions exhibiting lower volume have not been consistent across studies. In addition, it is not clear whether a common set of regions are involved in substance dependence regardless of the substance used or whether some brain volume effects are substance specific. Resolution of these issues may contribute to the identification of clinically relevant imaging biomarkers. Using pooled data from 14 countries, the authors sought to identify general and substance-specific associations between dependence and regional brain volumes.MethodBrain structure was examined in a mega-analysis of previously published data pooled from 23 laboratories, including 3,240 individuals, 2,140 of whom had substance dependence on one of five substances: alcohol, nicotine, cocaine, methamphetamine, or cannabis. Subcortical volume and cortical thickness in regions defined by FreeSurfer were compared with nondependent control subjects when all sampled substance categories were combined, as well as separately, while controlling for age, sex, imaging site, and total intracranial volume. Because of extensive associations with alcohol dependence, a secondary contrast was also performed for dependence on all substances except alcohol. An optimized split-half strategy was used to assess the reliability of the findings.ResultsLower volume or thickness was observed in many brain regions in individuals with substance dependence. The greatest effects were associated with alcohol use disorder. A set of affected regions related to dependence in general, regardless of the substance, included the insula and the medial orbitofrontal cortex. Furthermore, a support vector machine multivariate classification of regional brain volumes successfully classified individuals with substance dependence on alcohol or nicotine relative to nondependent control subje
Published: 2019

15. Adolescent brain cognitive development (ABCD) study: Overview of substance use assessment methods.

Author: Lisdahl, Krista M, Lisdahl, Krista M, Sher, Kenneth J, Conway, Kevin P, Gonzalez, Raul, Feldstein Ewing, Sarah W, Nixon, Sara Jo, Tapert, Susan, Bartsch, Hauke, Goldstein, Rita Z, Heitzeg, Mary, Lisdahl, Krista M, Lisdahl, Krista M, Sher, Kenneth J, Conway, Kevin P, Gonzalez, Raul, Feldstein Ewing, Sarah W, Nixon, Sara Jo, Tapert, Susan, Bartsch, Hauke, Goldstein, Rita Z, and Heitzeg, Mary
Abstract: One of the objectives of the Adolescent Brain Cognitive Development (ABCD) Study (https://abcdstudy.org/) is to establish a national longitudinal cohort of 9 and 10 year olds that will be followed for 10 years in order to prospectively study the risk and protective factors influencing substance use and its consequences, examine the impact of substance use on neurocognitive, health and psychosocial outcomes, and to understand the relationship between substance use and psychopathology. This article provides an overview of the ABCD Study Substance Use Workgroup, provides the goals for the workgroup, rationale for the substance use battery, and includes details on the substance use module methods and measurement tools used during baseline, 6-month and 1-year follow-up assessment time-points. Prospective, longitudinal assessment of these substance use domains over a period of ten years in a nationwide sample of youth presents an unprecedented opportunity to further understand the timing and interactive relationships between substance use and neurocognitive, health, and psychopathology outcomes in youth living in the United States.
Published: 2018

16. Low Striatal Dopamine D2-type Receptor Availability is Linked to Simulated Drug Choice in Methamphetamine Users.

Author: Moeller, Scott J, Moeller, Scott J, Okita, Kyoji, Robertson, Chelsea L, Ballard, Michael E, Konova, Anna B, Goldstein, Rita Z, Mandelkern, Mark A, London, Edythe D, Moeller, Scott J, Moeller, Scott J, Okita, Kyoji, Robertson, Chelsea L, Ballard, Michael E, Konova, Anna B, Goldstein, Rita Z, Mandelkern, Mark A, and London, Edythe D
Abstract: Individuals with drug use disorders seek drugs over other rewarding activities, and exhibit neurochemical deficits related to dopamine, which is involved in value-based learning and decision-making. Thus, a dopaminergic disturbance may underpin drug-biased choice in addiction. Classical drug-choice assessments, which offer drug-consumption opportunities, are inappropriate for addicted individuals seeking treatment or abstaining. Fifteen recently abstinent methamphetamine users and 15 healthy controls completed two laboratory paradigms of 'simulated' drug choice (choice for drug-related vs affectively pleasant, unpleasant, and neutral images), and underwent positron emission tomography measurements of dopamine D2-type receptor availability, indicated by binding potential (BPND) for [18F]fallypride. Thirteen of the methamphetamine users and 10 controls also underwent [11C]NNC112 PET scans to measure dopamine D1-type receptor availability. Group analyses showed that, compared with controls, methamphetamine users chose to view more methamphetamine-related images on one task, with a similar trend on the second task. Regression analyses showed that, on both tasks, the more methamphetamine users chose to view methamphetamine images, specifically vs pleasant images (the most frequently chosen images across all participants), the lower was their D2-type BPND in the lateral orbitofrontal cortex, an important region in value-based choice. No associations were observed with D2-type BPND in striatal regions, or with D1-type BPND in any region. These results identify a neurochemical correlate for a laboratory drug-seeking paradigm that can be administered to treatment-seeking and abstaining drug-addicted individuals. More broadly, these results refine the central hypothesis that dopamine-system deficits contribute to drug-biased decision-making in addiction, here showing a role for the orbitofrontal cortex.
Published: 2018

17. Adolescent brain cognitive development (ABCD) study: Overview of substance use assessment methods.

Author: Lisdahl, Krista M, Lisdahl, Krista M, Sher, Kenneth J, Conway, Kevin P, Gonzalez, Raul, Feldstein Ewing, Sarah W, Nixon, Sara Jo, Tapert, Susan, Bartsch, Hauke, Goldstein, Rita Z, Heitzeg, Mary, Lisdahl, Krista M, Lisdahl, Krista M, Sher, Kenneth J, Conway, Kevin P, Gonzalez, Raul, Feldstein Ewing, Sarah W, Nixon, Sara Jo, Tapert, Susan, Bartsch, Hauke, Goldstein, Rita Z, and Heitzeg, Mary
Abstract: One of the objectives of the Adolescent Brain Cognitive Development (ABCD) Study (https://abcdstudy.org/) is to establish a national longitudinal cohort of 9 and 10 year olds that will be followed for 10 years in order to prospectively study the risk and protective factors influencing substance use and its consequences, examine the impact of substance use on neurocognitive, health and psychosocial outcomes, and to understand the relationship between substance use and psychopathology. This article provides an overview of the ABCD Study Substance Use Workgroup, provides the goals for the workgroup, rationale for the substance use battery, and includes details on the substance use module methods and measurement tools used during baseline, 6-month and 1-year follow-up assessment time-points. Prospective, longitudinal assessment of these substance use domains over a period of ten years in a nationwide sample of youth presents an unprecedented opportunity to further understand the timing and interactive relationships between substance use and neurocognitive, health, and psychopathology outcomes in youth living in the United States.
Published: 2018

18. Low Striatal Dopamine D2-type Receptor Availability is Linked to Simulated Drug Choice in Methamphetamine Users.

Author: Moeller, Scott J, Moeller, Scott J, Okita, Kyoji, Robertson, Chelsea L, Ballard, Michael E, Konova, Anna B, Goldstein, Rita Z, Mandelkern, Mark A, London, Edythe D, Moeller, Scott J, Moeller, Scott J, Okita, Kyoji, Robertson, Chelsea L, Ballard, Michael E, Konova, Anna B, Goldstein, Rita Z, Mandelkern, Mark A, and London, Edythe D
Abstract: Individuals with drug use disorders seek drugs over other rewarding activities, and exhibit neurochemical deficits related to dopamine, which is involved in value-based learning and decision-making. Thus, a dopaminergic disturbance may underpin drug-biased choice in addiction. Classical drug-choice assessments, which offer drug-consumption opportunities, are inappropriate for addicted individuals seeking treatment or abstaining. Fifteen recently abstinent methamphetamine users and 15 healthy controls completed two laboratory paradigms of 'simulated' drug choice (choice for drug-related vs affectively pleasant, unpleasant, and neutral images), and underwent positron emission tomography measurements of dopamine D2-type receptor availability, indicated by binding potential (BPND) for [18F]fallypride. Thirteen of the methamphetamine users and 10 controls also underwent [11C]NNC112 PET scans to measure dopamine D1-type receptor availability. Group analyses showed that, compared with controls, methamphetamine users chose to view more methamphetamine-related images on one task, with a similar trend on the second task. Regression analyses showed that, on both tasks, the more methamphetamine users chose to view methamphetamine images, specifically vs pleasant images (the most frequently chosen images across all participants), the lower was their D2-type BPND in the lateral orbitofrontal cortex, an important region in value-based choice. No associations were observed with D2-type BPND in striatal regions, or with D1-type BPND in any region. These results identify a neurochemical correlate for a laboratory drug-seeking paradigm that can be administered to treatment-seeking and abstaining drug-addicted individuals. More broadly, these results refine the central hypothesis that dopamine-system deficits contribute to drug-biased decision-making in addiction, here showing a role for the orbitofrontal cortex.
Published: 2018

19. Low Striatal Dopamine D2-type Receptor Availability is Linked to Simulated Drug Choice in Methamphetamine Users

Author: Moeller, Scott J, Moeller, Scott J, Okita, Kyoji, Robertson, Chelsea L, Ballard, Michael E, Konova, Anna B, Goldstein, Rita Z, Mandelkern, Mark A, London, Edythe D, Moeller, Scott J, Moeller, Scott J, Okita, Kyoji, Robertson, Chelsea L, Ballard, Michael E, Konova, Anna B, Goldstein, Rita Z, Mandelkern, Mark A, and London, Edythe D
Abstract: Individuals with drug use disorders seek drugs over other rewarding activities, and exhibit neurochemical deficits related to dopamine, which is involved in value-based learning and decision-making. Thus, a dopaminergic disturbance may underpin drug-biased choice in addiction. Classical drug-choice assessments, which offer drug-consumption opportunities, are inappropriate for addicted individuals seeking treatment or abstaining. Fifteen recently abstinent methamphetamine users and 15 healthy controls completed two laboratory paradigms of 'simulated' drug choice (choice for drug-related vs affectively pleasant, unpleasant, and neutral images), and underwent positron emission tomography measurements of dopamine D2-type receptor availability, indicated by binding potential (BPND) for [18F]fallypride. Thirteen of the methamphetamine users and 10 controls also underwent [11C]NNC112 PET scans to measure dopamine D1-type receptor availability. Group analyses showed that, compared with controls, methamphetamine users chose to view more methamphetamine-related images on one task, with a similar trend on the second task. Regression analyses showed that, on both tasks, the more methamphetamine users chose to view methamphetamine images, specifically vs pleasant images (the most frequently chosen images across all participants), the lower was their D2-type BPND in the lateral orbitofrontal cortex, an important region in value-based choice. No associations were observed with D2-type BPND in striatal regions, or with D1-type BPND in any region. These results identify a neurochemical correlate for a laboratory drug-seeking paradigm that can be administered to treatment-seeking and abstaining drug-addicted individuals. More broadly, these results refine the central hypothesis that dopamine-system deficits contribute to drug-biased decision-making in addiction, here showing a role for the orbitofrontal cortex.
Published: 2018

20. The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data

Author: Massachusetts Institute of Technology. Department of Brain and Cognitive Sciences, Smoller, Jordan, Thompson, Paul M, Stein, Jason L, Medland, Sarah E, Hibar, Derrek P, Vasquez, Alejandro A, Renteria, Miguel E, Toro, Roberto, Jahanshad, Neda, Schumann, Gunter, Franke, Barbara, Wright, Margaret J, Martin, Nicholas G, Agartz, Ingrid, Alda, Martin, Alhusaini, Saud, Almasy, Laura, Almeida, Jorge, Alpert, Kathryn, Andreasen, Nancy C, Andreassen, Ole A, Apostolova, Liana G, Appel, Katja, Armstrong, Nicola J, Aribisala, Benjamin, Bastin, Mark E, Bauer, Michael, Bearden, Carrie E, Bergmann, Ørjan, Binder, Elisabeth B, Blangero, John, Bockholt, Henry J, Bøen, Erlend, Bois, Catherine, Boomsma, Dorret I, Booth, Tom, Bowman, Ian J, Bralten, Janita, Brouwer, Rachel M, Brunner, Han G, Brohawn, David G, Buckner, Randy L, Buitelaar, Jan, Bulayeva, Kazima, Bustillo, Juan R, Calhoun, Vince D, Cannon, Dara M, Cantor, Rita M, Carless, Melanie A, Caseras, Xavier, Cavalleri, Gianpiero L, Chakravarty, M. M, Chang, Kiki D, Ching, Christopher R K, Christoforou, Andrea, Cichon, Sven, Clark, Vincent P, Conrod, Patricia, Coppola, Giovanni, Crespo-Facorro, Benedicto, Curran, Joanne E, Czisch, Michael, Deary, Ian J, de Geus, Eco J C, den Braber, Anouk, Delvecchio, Giuseppe, Depondt, Chantal, de Haan, Lieuwe, de Zubicaray, Greig I, Dima, Danai, Dimitrova, Rali, Djurovic, Srdjan, Dong, Hongwei, Donohoe, Gary, Duggirala, Ravindranath, Dyer, Thomas D, Ehrlich, Stefan, Ekman, Carl J, Elvsåshagen, Torbjørn, Emsell, Louise, Erk, Susanne, Espeseth, Thomas, Fagerness, Jesen, Fears, Scott, Fedko, Iryna, Fernández, Guillén, Fisher, Simon E, Foroud, Tatiana, Fox, Peter T, Francks, Clyde, Frangou, Sophia, Frey, Eva M, Frodl, Thomas, Frouin, Vincent, Garavan, Hugh, Giddaluru, Sudheer, Glahn, David C, Godlewska, Beata, Goldstein, Rita Z, Gollub, Randy L, Grabe, Hans J, Grimm, Oliver, Gruber, Oliver, Guadalupe, Tulio, Gur, Raquel E, Gur, Ruben C, Göring, Harald H H, Hagenaars, Saskia, Hajek, Tomas, Hall, Geoffrey B, Hall, Jeremy, Hardy, John, Hartman, Catharina A, Hass, Johanna, Hatton, Sean N, Haukvik, Unn K, Hegenscheid, Katrin, Heinz, Andreas, Hickie, Ian B, Ho, Beng-Choon, Hoehn, David, Hoekstra, Pieter J, Hollinshead, Marisa, Holmes, Avram J, Homuth, Georg, Hoogman, Martine, Hong, L. E, Hosten, Norbert, Hottenga, Jouke-Jan, Hulshoff Pol, Hilleke E, Hwang, Kristy S, Jack, Clifford R, Jenkinson, Mark, Johnston, Caroline, Jönsson, Erik G, Kahn, René S, Kasperaviciute, Dalia, Kelly, Sinead, Kim, Sungeun, Kochunov, Peter, Koenders, Laura, Krämer, Bernd, Kwok, John B J, Lagopoulos, Jim, Laje, Gonzalo, Landen, Mikael, Landman, Bennett A, Lauriello, John, Lawrie, Stephen M, Lee, Phil H, Le Hellard, Stephanie, Lemaître, Herve, Leonardo, Cassandra D, Li, Chiang-shan, Liberg, Benny, Liewald, David C, Liu, Xinmin, Lopez, Lorna M, Loth, Eva, Lourdusamy, Anbarasu, Luciano, Michelle, Macciardi, Fabio, Machielsen, Marise W J, MacQueen, Glenda M, Malt, Ulrik F, Mandl, René, Manoach, Dara S, Martinot, Jean-Luc, Matarin, Mar, Mather, Karen A, Mattheisen, Manuel, Mattingsdal, Morten, Meyer-Lindenberg, Andreas, McDonald, Colm, McIntosh, Andrew M, McMahon, Francis J, McMahon, Katie L, Meisenzahl, Eva, Melle, Ingrid, Milaneschi, Yuri, Mohnke, Sebastian, Montgomery, Grant W, Morris, Derek W, Moses, Eric K, Mueller, Bryon A, Muñoz Maniega, Susana, Mühleisen, Thomas W, Müller-Myhsok, Bertram, Mwangi, Benson, Nauck, Matthias, Nho, Kwangsik, Nichols, Thomas E, Nilsson, Lars-Göran, Nugent, Allison C, Nyberg, Lars, Olvera, Rene L, Oosterlaan, Jaap, Ophoff, Roel A, Pandolfo, Massimo, Papalampropoulou-Tsiridou, Melina, Papmeyer, Martina, Paus, Tomas, Pausova, Zdenka, Pearlson, Godfrey D, Penninx, Brenda W, Peterson, Charles P, Pfennig, Andrea, Phillips, Mary, Pike, G. B, Poline, Jean-Baptiste, Potkin, Steven G, Pütz, Benno, Ramasamy, Adaikalavan, Rasmussen, Jerod, Rietschel, Marcella, Rijpkema, Mark, Risacher, Shannon L, Roffman, Joshua L, Roiz-Santiañez, Roberto, Romanczuk-Seiferth, Nina, Rose, Emma J, Royle, Natalie A, Rujescu, Dan, Ryten, Mina, Sachdev, Perminder S, Salami, Alireza, Satterthwaite, Theodore D, Savitz, Jonathan, Saykin, Andrew J, Scanlon, Cathy, Schmaal, Lianne, Schnack, Hugo G, Schork, Andrew J, Schulz, S. C, Schür, Remmelt, Seidman, Larry, Shen, Li, Shoemaker, Jody M, Simmons, Andrew, Sisodiya, Sanjay M, Smith, Colin, Soares, Jair C, Sponheim, Scott R, Sprooten, Emma, Starr, John M, Steen, Vidar M, Strakowski, Stephen, Strike, Lachlan, Sussmann, Jessika, Sämann, Philipp G, Teumer, Alexander, Toga, Arthur W, Tordesillas-Gutierrez, Diana, Trabzuni, Daniah, Trost, Sarah, Turner, Jessica, Van den Heuvel, Martijn, van der Wee, Nic J, van Eijk, Kristel, van Erp, Theo G M, van Haren, Neeltje E M, van ‘t Ent, Dennis, van Tol, Marie-Jose, Valdés Hernández, Maria C, Veltman, Dick J, Versace, Amelia, Völzke, Henry, Walker, Robert, Walter, Henrik, Wang, Lei, Wardlaw, Joanna M, Weale, Michael E, Weiner, Michael W, Wen, Wei, Westlye, Lars T, Whalley, Heather C, Whelan, Christopher D, White, Tonya, Winkler, Anderson M, Wittfeld, Katharina, Woldehawariat, Girma, Wolf, Christiane, Zilles, David, Zwiers, Marcel P, Thalamuthu, Anbupalam, Schofield, Peter R, Freimer, Nelson B, Lawrence, Natalia S, Drevets, Wayne, Massachusetts Institute of Technology. Department of Brain and Cognitive Sciences, Smoller, Jordan, Thompson, Paul M, Stein, Jason L, Medland, Sarah E, Hibar, Derrek P, Vasquez, Alejandro A, Renteria, Miguel E, Toro, Roberto, Jahanshad, Neda, Schumann, Gunter, Franke, Barbara, Wright, Margaret J, Martin, Nicholas G, Agartz, Ingrid, Alda, Martin, Alhusaini, Saud, Almasy, Laura, Almeida, Jorge, Alpert, Kathryn, Andreasen, Nancy C, Andreassen, Ole A, Apostolova, Liana G, Appel, Katja, Armstrong, Nicola J, Aribisala, Benjamin, Bastin, Mark E, Bauer, Michael, Bearden, Carrie E, Bergmann, Ørjan, Binder, Elisabeth B, Blangero, John, Bockholt, Henry J, Bøen, Erlend, Bois, Catherine, Boomsma, Dorret I, Booth, Tom, Bowman, Ian J, Bralten, Janita, Brouwer, Rachel M, Brunner, Han G, Brohawn, David G, Buckner, Randy L, Buitelaar, Jan, Bulayeva, Kazima, Bustillo, Juan R, Calhoun, Vince D, Cannon, Dara M, Cantor, Rita M, Carless, Melanie A, Caseras, Xavier, Cavalleri, Gianpiero L, Chakravarty, M. M, Chang, Kiki D, Ching, Christopher R K, Christoforou, Andrea, Cichon, Sven, Clark, Vincent P, Conrod, Patricia, Coppola, Giovanni, Crespo-Facorro, Benedicto, Curran, Joanne E, Czisch, Michael, Deary, Ian J, de Geus, Eco J C, den Braber, Anouk, Delvecchio, Giuseppe, Depondt, Chantal, de Haan, Lieuwe, de Zubicaray, Greig I, Dima, Danai, Dimitrova, Rali, Djurovic, Srdjan, Dong, Hongwei, Donohoe, Gary, Duggirala, Ravindranath, Dyer, Thomas D, Ehrlich, Stefan, Ekman, Carl J, Elvsåshagen, Torbjørn, Emsell, Louise, Erk, Susanne, Espeseth, Thomas, Fagerness, Jesen, Fears, Scott, Fedko, Iryna, Fernández, Guillén, Fisher, Simon E, Foroud, Tatiana, Fox, Peter T, Francks, Clyde, Frangou, Sophia, Frey, Eva M, Frodl, Thomas, Frouin, Vincent, Garavan, Hugh, Giddaluru, Sudheer, Glahn, David C, Godlewska, Beata, Goldstein, Rita Z, Gollub, Randy L, Grabe, Hans J, Grimm, Oliver, Gruber, Oliver, Guadalupe, Tulio, Gur, Raquel E, Gur, Ruben C, Göring, Harald H H, Hagenaars, Saskia, Hajek, Tomas, Hall, Geoffrey B, Hall, Jeremy, Hardy, John, Hartman, Catharina A, Hass, Johanna, Hatton, Sean N, Haukvik, Unn K, Hegenscheid, Katrin, Heinz, Andreas, Hickie, Ian B, Ho, Beng-Choon, Hoehn, David, Hoekstra, Pieter J, Hollinshead, Marisa, Holmes, Avram J, Homuth, Georg, Hoogman, Martine, Hong, L. E, Hosten, Norbert, Hottenga, Jouke-Jan, Hulshoff Pol, Hilleke E, Hwang, Kristy S, Jack, Clifford R, Jenkinson, Mark, Johnston, Caroline, Jönsson, Erik G, Kahn, René S, Kasperaviciute, Dalia, Kelly, Sinead, Kim, Sungeun, Kochunov, Peter, Koenders, Laura, Krämer, Bernd, Kwok, John B J, Lagopoulos, Jim, Laje, Gonzalo, Landen, Mikael, Landman, Bennett A, Lauriello, John, Lawrie, Stephen M, Lee, Phil H, Le Hellard, Stephanie, Lemaître, Herve, Leonardo, Cassandra D, Li, Chiang-shan, Liberg, Benny, Liewald, David C, Liu, Xinmin, Lopez, Lorna M, Loth, Eva, Lourdusamy, Anbarasu, Luciano, Michelle, Macciardi, Fabio, Machielsen, Marise W J, MacQueen, Glenda M, Malt, Ulrik F, Mandl, René, Manoach, Dara S, Martinot, Jean-Luc, Matarin, Mar, Mather, Karen A, Mattheisen, Manuel, Mattingsdal, Morten, Meyer-Lindenberg, Andreas, McDonald, Colm, McIntosh, Andrew M, McMahon, Francis J, McMahon, Katie L, Meisenzahl, Eva, Melle, Ingrid, Milaneschi, Yuri, Mohnke, Sebastian, Montgomery, Grant W, Morris, Derek W, Moses, Eric K, Mueller, Bryon A, Muñoz Maniega, Susana, Mühleisen, Thomas W, Müller-Myhsok, Bertram, Mwangi, Benson, Nauck, Matthias, Nho, Kwangsik, Nichols, Thomas E, Nilsson, Lars-Göran, Nugent, Allison C, Nyberg, Lars, Olvera, Rene L, Oosterlaan, Jaap, Ophoff, Roel A, Pandolfo, Massimo, Papalampropoulou-Tsiridou, Melina, Papmeyer, Martina, Paus, Tomas, Pausova, Zdenka, Pearlson, Godfrey D, Penninx, Brenda W, Peterson, Charles P, Pfennig, Andrea, Phillips, Mary, Pike, G. B, Poline, Jean-Baptiste, Potkin, Steven G, Pütz, Benno, Ramasamy, Adaikalavan, Rasmussen, Jerod, Rietschel, Marcella, Rijpkema, Mark, Risacher, Shannon L, Roffman, Joshua L, Roiz-Santiañez, Roberto, Romanczuk-Seiferth, Nina, Rose, Emma J, Royle, Natalie A, Rujescu, Dan, Ryten, Mina, Sachdev, Perminder S, Salami, Alireza, Satterthwaite, Theodore D, Savitz, Jonathan, Saykin, Andrew J, Scanlon, Cathy, Schmaal, Lianne, Schnack, Hugo G, Schork, Andrew J, Schulz, S. C, Schür, Remmelt, Seidman, Larry, Shen, Li, Shoemaker, Jody M, Simmons, Andrew, Sisodiya, Sanjay M, Smith, Colin, Soares, Jair C, Sponheim, Scott R, Sprooten, Emma, Starr, John M, Steen, Vidar M, Strakowski, Stephen, Strike, Lachlan, Sussmann, Jessika, Sämann, Philipp G, Teumer, Alexander, Toga, Arthur W, Tordesillas-Gutierrez, Diana, Trabzuni, Daniah, Trost, Sarah, Turner, Jessica, Van den Heuvel, Martijn, van der Wee, Nic J, van Eijk, Kristel, van Erp, Theo G M, van Haren, Neeltje E M, van ‘t Ent, Dennis, van Tol, Marie-Jose, Valdés Hernández, Maria C, Veltman, Dick J, Versace, Amelia, Völzke, Henry, Walker, Robert, Walter, Henrik, Wang, Lei, Wardlaw, Joanna M, Weale, Michael E, Weiner, Michael W, Wen, Wei, Westlye, Lars T, Whalley, Heather C, Whelan, Christopher D, White, Tonya, Winkler, Anderson M, Wittfeld, Katharina, Woldehawariat, Girma, Wolf, Christiane, Zilles, David, Zwiers, Marcel P, Thalamuthu, Anbupalam, Schofield, Peter R, Freimer, Nelson B, Lawrence, Natalia S, and Drevets, Wayne
Abstract: The Enhancing NeuroImaging Genetics through Meta-Analysis (ENIGMA) Consortium is a collaborative network of researchers working together on a range of large-scale studies that integrate data from 70 institutions worldwide. Organized into Working Groups that tackle questions in neuroscience, genetics, and medicine, ENIGMA studies have analyzed neuroimaging data from over 12,826 subjects. In addition, data from 12,171 individuals were provided by the CHARGE consortium for replication of findings, in a total of 24,997 subjects. By meta-analyzing results from many sites, ENIGMA has detected factors that affect the brain that no individual site could detect on its own, and that require larger numbers of subjects than any individual neuroimaging study has currently collected. ENIGMA’s first project was a genome-wide association study identifying common variants in the genome associated with hippocampal volume or intracranial volume. Continuing work is exploring genetic associations with subcortical volumes (ENIGMA2) and white matter microstructure (ENIGMA-DTI). Working groups also focus on understanding how schizophrenia, bipolar illness, major depression and attention deficit/hyperactivity disorder (ADHD) affect the brain. We review the current progress of the ENIGMA Consortium, along with challenges and unexpected discoveries made on the way.
Published: 2017

21. Genetic imaging consortium for addiction medicine: From neuroimaging to genes.

Author: Mackey, Scott, Mackey, Scott, Kan, Kees-Jan, Chaarani, Bader, Alia-Klein, Nelly, Batalla, Albert, Brooks, Samantha, Cousijn, Janna, Dagher, Alain, de Ruiter, Michiel, Desrivieres, Sylvane, Feldstein Ewing, Sarah W, Goldstein, Rita Z, Goudriaan, Anna E, Heitzeg, Mary M, Hutchison, Kent, Li, Chiang-Shan R, London, Edythe D, Lorenzetti, Valentina, Luijten, Maartje, Martin-Santos, Rocio, Morales, Angelica M, Paulus, Martin P, Paus, Tomas, Pearlson, Godfrey, Schluter, Renée, Momenan, Reza, Schmaal, Lianne, Schumann, Gunter, Sinha, Rajita, Sjoerds, Zsuzsika, Stein, Dan J, Stein, Elliot A, Solowij, Nadia, Tapert, Susan, Uhlmann, Anne, Veltman, Dick, van Holst, Ruth, Walter, Henrik, Wright, Margaret J, Yucel, Murat, Yurgelun-Todd, Deborah, Hibar, Derrek P, Jahanshad, Neda, Thompson, Paul M, Glahn, David C, Garavan, Hugh, Conrod, Patricia, Mackey, Scott, Mackey, Scott, Kan, Kees-Jan, Chaarani, Bader, Alia-Klein, Nelly, Batalla, Albert, Brooks, Samantha, Cousijn, Janna, Dagher, Alain, de Ruiter, Michiel, Desrivieres, Sylvane, Feldstein Ewing, Sarah W, Goldstein, Rita Z, Goudriaan, Anna E, Heitzeg, Mary M, Hutchison, Kent, Li, Chiang-Shan R, London, Edythe D, Lorenzetti, Valentina, Luijten, Maartje, Martin-Santos, Rocio, Morales, Angelica M, Paulus, Martin P, Paus, Tomas, Pearlson, Godfrey, Schluter, Renée, Momenan, Reza, Schmaal, Lianne, Schumann, Gunter, Sinha, Rajita, Sjoerds, Zsuzsika, Stein, Dan J, Stein, Elliot A, Solowij, Nadia, Tapert, Susan, Uhlmann, Anne, Veltman, Dick, van Holst, Ruth, Walter, Henrik, Wright, Margaret J, Yucel, Murat, Yurgelun-Todd, Deborah, Hibar, Derrek P, Jahanshad, Neda, Thompson, Paul M, Glahn, David C, Garavan, Hugh, and Conrod, Patricia
Abstract: Since the sample size of a typical neuroimaging study lacks sufficient statistical power to explore unknown genomic associations with brain phenotypes, several international genetic imaging consortia have been organized in recent years to pool data across sites. The challenges and achievements of these consortia are considered here with the goal of leveraging these resources to study addiction. The authors of this review have joined together to form an Addiction working group within the framework of the ENIGMA project, a meta-analytic approach to multisite genetic imaging data. Collectively, the Addiction working group possesses neuroimaging and genomic data obtained from over 10,000 subjects. The deadline for contributing data to the first round of analyses occurred at the beginning of May 2015. The studies performed on this data should significantly impact our understanding of the genetic and neurobiological basis of addiction.
Published: 2016

22. Genetic imaging consortium for addiction medicine: From neuroimaging to genes.

Author: Mackey, Scott, Mackey, Scott, Kan, Kees-Jan, Chaarani, Bader, Alia-Klein, Nelly, Batalla, Albert, Brooks, Samantha, Cousijn, Janna, Dagher, Alain, de Ruiter, Michiel, Desrivieres, Sylvane, Feldstein Ewing, Sarah W, Goldstein, Rita Z, Goudriaan, Anna E, Heitzeg, Mary M, Hutchison, Kent, Li, Chiang-Shan R, London, Edythe D, Lorenzetti, Valentina, Luijten, Maartje, Martin-Santos, Rocio, Morales, Angelica M, Paulus, Martin P, Paus, Tomas, Pearlson, Godfrey, Schluter, Renée, Momenan, Reza, Schmaal, Lianne, Schumann, Gunter, Sinha, Rajita, Sjoerds, Zsuzsika, Stein, Dan J, Stein, Elliot A, Solowij, Nadia, Tapert, Susan, Uhlmann, Anne, Veltman, Dick, van Holst, Ruth, Walter, Henrik, Wright, Margaret J, Yucel, Murat, Yurgelun-Todd, Deborah, Hibar, Derrek P, Jahanshad, Neda, Thompson, Paul M, Glahn, David C, Garavan, Hugh, Conrod, Patricia, Mackey, Scott, Mackey, Scott, Kan, Kees-Jan, Chaarani, Bader, Alia-Klein, Nelly, Batalla, Albert, Brooks, Samantha, Cousijn, Janna, Dagher, Alain, de Ruiter, Michiel, Desrivieres, Sylvane, Feldstein Ewing, Sarah W, Goldstein, Rita Z, Goudriaan, Anna E, Heitzeg, Mary M, Hutchison, Kent, Li, Chiang-Shan R, London, Edythe D, Lorenzetti, Valentina, Luijten, Maartje, Martin-Santos, Rocio, Morales, Angelica M, Paulus, Martin P, Paus, Tomas, Pearlson, Godfrey, Schluter, Renée, Momenan, Reza, Schmaal, Lianne, Schumann, Gunter, Sinha, Rajita, Sjoerds, Zsuzsika, Stein, Dan J, Stein, Elliot A, Solowij, Nadia, Tapert, Susan, Uhlmann, Anne, Veltman, Dick, van Holst, Ruth, Walter, Henrik, Wright, Margaret J, Yucel, Murat, Yurgelun-Todd, Deborah, Hibar, Derrek P, Jahanshad, Neda, Thompson, Paul M, Glahn, David C, Garavan, Hugh, and Conrod, Patricia
Abstract: Since the sample size of a typical neuroimaging study lacks sufficient statistical power to explore unknown genomic associations with brain phenotypes, several international genetic imaging consortia have been organized in recent years to pool data across sites. The challenges and achievements of these consortia are considered here with the goal of leveraging these resources to study addiction. The authors of this review have joined together to form an Addiction working group within the framework of the ENIGMA project, a meta-analytic approach to multisite genetic imaging data. Collectively, the Addiction working group possesses neuroimaging and genomic data obtained from over 10,000 subjects. The deadline for contributing data to the first round of analyses occurred at the beginning of May 2015. The studies performed on this data should significantly impact our understanding of the genetic and neurobiological basis of addiction.
Published: 2016

23. The ENIGMA Consortium : large-scale collaborative analyses of neuroimaging and genetic data

Author: Thompson, Paul M., Stein, Jason L., Medland, Sarah E., Hibar, Derrek P., Vasquez, Alejandro Arias, Renteria, Miguel E., Toro, Roberto, Jahanshad, Neda, Schumann, Gunter, Franke, Barbara, Wright, Margaret J., Martin, Nicholas G., Agartz, Ingrid, Alda, Martin, Alhusaini, Saud, Almasy, Laura, Almeida, Jorge, Alpert, Kathryn, Andreasen, Nancy C., Andreassen, Ole A., Apostolova, Liana G., Appel, Katja, Armstrong, Nicola J., Aribisala, Benjamin, Bastin, Mark E., Bauer, Michael, Bearden, Carrie E., Bergmann, Orjan, Binder, Elisabeth B., Blangero, John, Bockholt, Henry J., Boen, Erlend, Bois, Catherine, Boomsma, Dorret I., Booth, Tom, Bowman, Ian J., Bralten, Janita, Brouwer, Rachel M., Brunner, Han G., Brohawn, David G., Buckner, Randy L., Buitelaar, Jan, Bulayeva, Kazima, Bustillo, Juan R., Calhoun, Vince D., Cannon, Dara M., Cantor, Rita M., Carless, Melanie A., Caseras, Xavier, Cavalleri, Gianpiero L., Chakravarty, M. Mallar, Chang, Kiki D., Ching, Christopher R. K., Christoforou, Andrea, Cichon, Sven, Clark, Vincent P., Conrod, Patricia, Coppola, Giovanni, Crespo-Facorro, Benedicto, Curran, Joanne E., Czisch, Michael, Deary, Ian J., de Geus, Eco J. C., den Braber, Anouk, Delvecchio, Giuseppe, Depondt, Chantal, de Haan, Lieuwe, de Zubicaray, Greig I., Dima, Danai, Dimitrova, Rali, Djurovic, Srdjan, Dong, Hongwei, Donohoe, Gary, Duggirala, Ravindranath, Dyer, Thomas D., Ehrlich, Stefan, Ekman, Carl Johan, Elvsashagen, Torbjorn, Emsell, Louise, Erk, Susanne, Espeseth, Thomas, Fagerness, Jesen, Fears, Scott, Fedko, Iryna, Fernandez, Guillen, Fisher, Simon E., Foroud, Tatiana, Fox, Peter T., Francks, Clyde, Frangou, Sophia, Frey, Eva Maria, Frodl, Thomas, Frouin, Vincent, Garavan, Hugh, Giddaluru, Sudheer, Glahn, David C., Godlewska, Beata, Goldstein, Rita Z., Gollub, Randy L., Grabe, Hans J., Grimm, Oliver, Gruber, Oliver, Guadalupe, Tulio, Gur, Raquel E., Gur, Ruben C., Goering, Harald H. H., Hagenaars, Saskia, Hajek, Tomas, Hall, Geoffrey B., Hall, Jeremy, Hardy, John, Hartman, Catharina A., Hass, Johanna, Hatton, Sean N., Haukvik, Unn K., Hegenscheid, Katrin, Heinz, Andreas, Hickie, Ian B., Ho, Beng-Choon, Hoehn, David, Hoekstra, Pieter J., Hollinshead, Marisa, Holmes, Avram J., Homuth, Georg, Hoogman, Martine, Hong, L. Elliot, Hosten, Norbert, Hottenga, Jouke-Jan, Pol, Hilleke E. Hulshoff, Hwang, Kristy S., Jack, Clifford R., Jr., Jenkinson, Mark, Johnston, Caroline, Joensson, Erik G., Kahn, Rene S., Kasperaviciute, Dalia, Kelly, Sinead, Kim, Sungeun, Kochunov, Peter, Koenders, Laura, Kraemer, Bernd, Kwok, John B. J., Lagopoulos, Jim, Laje, Gonzalo, Landen, Mikael, Landman, Bennett A., Lauriello, John, Lawrie, Stephen M., Lee, Phil H., Le Hellard, Stephanie, Lemaitre, Herve, Leonardo, Cassandra D., Li, Chiang-shan, Liberg, Benny, Liewald, David C., Liu, Xinmin, Lopez, Lorna M., Loth, Eva, Lourdusamy, Anbarasu, Luciano, Michelle, Macciardi, Fabio, Machielsen, Marise W. J., MacQueen, Glenda M., Malt, Ulrik F., Mandl, Rene, Manoach, Dara S., Martinot, Jean-Luc, Matarin, Mar, Mather, Karen A., Mattheisen, Manuel, Mattingsdal, Morten, Meyer-Lindenberg, Andreas, McDonald, Colm, McIntosh, Andrew M., McMahon, Francis J., McMahon, Katie L., Meisenzahl, Eva, Melle, Ingrid, Milaneschi, Yuri, Mohnke, Sebastian, Montgomery, Grant W., Morris, Derek W., Moses, Eric K., Mueller, Bryon A., Maniega, Susana Munoz, Muehleisen, Thomas W., Mueller-Myhsok, Bertram, Mwangi, Benson, Nauck, Matthias, Nho, Kwangsik, Nichols, Thomas E., Nilsson, Lars-Goeran, Nugent, Allison C., Nyberg, Lars, Olvera, Rene L., Oosterlaan, Jaap, Ophoff, Roel A., Pandolfo, Massimo, Papalampropoulou-Tsiridou, Melina, Papmeyer, Martina, Paus, Tomas, Pausova, Zdenka, Pearlson, Godfrey D., Penninx, Brenda W., Peterson, Charles P., Pfennig, Andrea, Phillips, Mary, Pike, G. Bruce, Poline, Jean-Baptiste, Potkin, Steven G., Puetz, Benno, Ramasamy, Adaikalavan, Rasmussen, Jerod, Rietschel, Marcella, Rijpkema, Mark, Risacher, Shannon L., Roffman, Joshua L., Roiz-Santianez, Roberto, Romanczuk-Seiferth, Nina, Rose, Emma J., Royle, Natalie A., Rujescu, Dan, Ryten, Mina, Sachdev, Perminder S., Salami, Alireza, Satterthwaite, Theodore D., Savitz, Jonathan, Saykin, Andrew J., Scanlon, Cathy, Schmaal, Lianne, Schnack, Hugo G., Schork, Andrew J., Schulz, S. Charles, Schuer, Remmelt, Seidman, Larry, Shen, Li, Shoemaker, Jody M., Simmons, Andrew, Sisodiya, Sanjay M., Smith, Colin, Smoller, Jordan W., Soares, Jair C., Sponheim, Scott R., Sprooten, Emma, Starr, John M., Steen, Vidar M., Strakowski, Stephen, Strike, Lachlan, Sussmann, Jessika, Saemann, Philipp G., Teumer, Alexander, Toga, Arthur W., Tordesillas-Gutierrez, Diana, Trabzuni, Daniah, Trost, Sarah, Turner, Jessica, Van den Heuvel, Martijn, van der Wee, Nic J., van Eijk, Kristel, van Erp, Theo G. M., van Haren, Neeltje E. M., van 't Ent, Dennis, van Tol, Marie-Jose, Hernandez, Maria C. Valdes, Veltman, Dick J., Versace, Amelia, Voelzke, Henry, Walker, Robert, Walter, Henrik, Wang, Lei, Wardlaw, Joanna M., Weale, Michael E., Weiner, Michael W., Wen, Wei, Westlye, Lars T., Whalley, Heather C., Whelan, Christopher D., White, Tonya, Winkler, Anderson M., Wittfeld, Katharina, Woldehawariat, Girma, Wolf, Christiane, Zilles, David, Zwiers, Marcel P., Thalamuthu, Anbupalam, Schofield, Peter R., Freimer, Nelson B., Lawrence, Natalia S., Drevets, Wayne, Thompson, Paul M., Stein, Jason L., Medland, Sarah E., Hibar, Derrek P., Vasquez, Alejandro Arias, Renteria, Miguel E., Toro, Roberto, Jahanshad, Neda, Schumann, Gunter, Franke, Barbara, Wright, Margaret J., Martin, Nicholas G., Agartz, Ingrid, Alda, Martin, Alhusaini, Saud, Almasy, Laura, Almeida, Jorge, Alpert, Kathryn, Andreasen, Nancy C., Andreassen, Ole A., Apostolova, Liana G., Appel, Katja, Armstrong, Nicola J., Aribisala, Benjamin, Bastin, Mark E., Bauer, Michael, Bearden, Carrie E., Bergmann, Orjan, Binder, Elisabeth B., Blangero, John, Bockholt, Henry J., Boen, Erlend, Bois, Catherine, Boomsma, Dorret I., Booth, Tom, Bowman, Ian J., Bralten, Janita, Brouwer, Rachel M., Brunner, Han G., Brohawn, David G., Buckner, Randy L., Buitelaar, Jan, Bulayeva, Kazima, Bustillo, Juan R., Calhoun, Vince D., Cannon, Dara M., Cantor, Rita M., Carless, Melanie A., Caseras, Xavier, Cavalleri, Gianpiero L., Chakravarty, M. Mallar, Chang, Kiki D., Ching, Christopher R. K., Christoforou, Andrea, Cichon, Sven, Clark, Vincent P., Conrod, Patricia, Coppola, Giovanni, Crespo-Facorro, Benedicto, Curran, Joanne E., Czisch, Michael, Deary, Ian J., de Geus, Eco J. C., den Braber, Anouk, Delvecchio, Giuseppe, Depondt, Chantal, de Haan, Lieuwe, de Zubicaray, Greig I., Dima, Danai, Dimitrova, Rali, Djurovic, Srdjan, Dong, Hongwei, Donohoe, Gary, Duggirala, Ravindranath, Dyer, Thomas D., Ehrlich, Stefan, Ekman, Carl Johan, Elvsashagen, Torbjorn, Emsell, Louise, Erk, Susanne, Espeseth, Thomas, Fagerness, Jesen, Fears, Scott, Fedko, Iryna, Fernandez, Guillen, Fisher, Simon E., Foroud, Tatiana, Fox, Peter T., Francks, Clyde, Frangou, Sophia, Frey, Eva Maria, Frodl, Thomas, Frouin, Vincent, Garavan, Hugh, Giddaluru, Sudheer, Glahn, David C., Godlewska, Beata, Goldstein, Rita Z., Gollub, Randy L., Grabe, Hans J., Grimm, Oliver, Gruber, Oliver, Guadalupe, Tulio, Gur, Raquel E., Gur, Ruben C., Goering, Harald H. H., Hagenaars, Saskia, Hajek, Tomas, Hall, Geoffrey B., Hall, Jeremy, Hardy, John, Hartman, Catharina A., Hass, Johanna, Hatton, Sean N., Haukvik, Unn K., Hegenscheid, Katrin, Heinz, Andreas, Hickie, Ian B., Ho, Beng-Choon, Hoehn, David, Hoekstra, Pieter J., Hollinshead, Marisa, Holmes, Avram J., Homuth, Georg, Hoogman, Martine, Hong, L. Elliot, Hosten, Norbert, Hottenga, Jouke-Jan, Pol, Hilleke E. Hulshoff, Hwang, Kristy S., Jack, Clifford R., Jr., Jenkinson, Mark, Johnston, Caroline, Joensson, Erik G., Kahn, Rene S., Kasperaviciute, Dalia, Kelly, Sinead, Kim, Sungeun, Kochunov, Peter, Koenders, Laura, Kraemer, Bernd, Kwok, John B. J., Lagopoulos, Jim, Laje, Gonzalo, Landen, Mikael, Landman, Bennett A., Lauriello, John, Lawrie, Stephen M., Lee, Phil H., Le Hellard, Stephanie, Lemaitre, Herve, Leonardo, Cassandra D., Li, Chiang-shan, Liberg, Benny, Liewald, David C., Liu, Xinmin, Lopez, Lorna M., Loth, Eva, Lourdusamy, Anbarasu, Luciano, Michelle, Macciardi, Fabio, Machielsen, Marise W. J., MacQueen, Glenda M., Malt, Ulrik F., Mandl, Rene, Manoach, Dara S., Martinot, Jean-Luc, Matarin, Mar, Mather, Karen A., Mattheisen, Manuel, Mattingsdal, Morten, Meyer-Lindenberg, Andreas, McDonald, Colm, McIntosh, Andrew M., McMahon, Francis J., McMahon, Katie L., Meisenzahl, Eva, Melle, Ingrid, Milaneschi, Yuri, Mohnke, Sebastian, Montgomery, Grant W., Morris, Derek W., Moses, Eric K., Mueller, Bryon A., Maniega, Susana Munoz, Muehleisen, Thomas W., Mueller-Myhsok, Bertram, Mwangi, Benson, Nauck, Matthias, Nho, Kwangsik, Nichols, Thomas E., Nilsson, Lars-Goeran, Nugent, Allison C., Nyberg, Lars, Olvera, Rene L., Oosterlaan, Jaap, Ophoff, Roel A., Pandolfo, Massimo, Papalampropoulou-Tsiridou, Melina, Papmeyer, Martina, Paus, Tomas, Pausova, Zdenka, Pearlson, Godfrey D., Penninx, Brenda W., Peterson, Charles P., Pfennig, Andrea, Phillips, Mary, Pike, G. Bruce, Poline, Jean-Baptiste, Potkin, Steven G., Puetz, Benno, Ramasamy, Adaikalavan, Rasmussen, Jerod, Rietschel, Marcella, Rijpkema, Mark, Risacher, Shannon L., Roffman, Joshua L., Roiz-Santianez, Roberto, Romanczuk-Seiferth, Nina, Rose, Emma J., Royle, Natalie A., Rujescu, Dan, Ryten, Mina, Sachdev, Perminder S., Salami, Alireza, Satterthwaite, Theodore D., Savitz, Jonathan, Saykin, Andrew J., Scanlon, Cathy, Schmaal, Lianne, Schnack, Hugo G., Schork, Andrew J., Schulz, S. Charles, Schuer, Remmelt, Seidman, Larry, Shen, Li, Shoemaker, Jody M., Simmons, Andrew, Sisodiya, Sanjay M., Smith, Colin, Smoller, Jordan W., Soares, Jair C., Sponheim, Scott R., Sprooten, Emma, Starr, John M., Steen, Vidar M., Strakowski, Stephen, Strike, Lachlan, Sussmann, Jessika, Saemann, Philipp G., Teumer, Alexander, Toga, Arthur W., Tordesillas-Gutierrez, Diana, Trabzuni, Daniah, Trost, Sarah, Turner, Jessica, Van den Heuvel, Martijn, van der Wee, Nic J., van Eijk, Kristel, van Erp, Theo G. M., van Haren, Neeltje E. M., van 't Ent, Dennis, van Tol, Marie-Jose, Hernandez, Maria C. Valdes, Veltman, Dick J., Versace, Amelia, Voelzke, Henry, Walker, Robert, Walter, Henrik, Wang, Lei, Wardlaw, Joanna M., Weale, Michael E., Weiner, Michael W., Wen, Wei, Westlye, Lars T., Whalley, Heather C., Whelan, Christopher D., White, Tonya, Winkler, Anderson M., Wittfeld, Katharina, Woldehawariat, Girma, Wolf, Christiane, Zilles, David, Zwiers, Marcel P., Thalamuthu, Anbupalam, Schofield, Peter R., Freimer, Nelson B., Lawrence, Natalia S., and Drevets, Wayne
Abstract: The Enhancing NeuroImaging Genetics through Meta-Analysis (ENIGMA) Consortium is a collaborative network of researchers working together on a range of large-scale studies that integrate data from 70 institutions worldwide. Organized into Working Groups that tackle questions in neuroscience, genetics, and medicine, ENIGMA studies have analyzed neuroimaging data from over 12,826 subjects. In addition, data from 12,171 individuals were provided by the CHARGE consortium for replication of findings, in a total of 24,997 subjects. By meta-analyzing results from many sites, ENIGMA has detected factors that affect the brain that no individual site could detect on its own, and that require larger numbers of subjects than any individual neuroimaging study has currently collected. ENIGMA's first project was a genome-wide association study identifying common variants in the genome associated with hippocampal volume or intracranial volume. Continuing work is exploring genetic associations with subcortical volumes (ENIGMA2) and white matter microstructure (ENIGMA-DTI). Working groups also focus on understanding how schizophrenia, bipolar illness, major depression and attention deficit/hyperactivity disorder (ADHD) affect the brain. We review the current progress of the ENIGMA Consortium, along with challenges and unexpected discoveries made on the way.
Published: 2014
Full Text: View/download PDF

24. The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data.

Author: Thompson, Paul M, Thompson, Paul M, Stein, Jason L, Medland, Sarah E, Hibar, Derrek P, Vasquez, Alejandro Arias, Renteria, Miguel E, Toro, Roberto, Jahanshad, Neda, Schumann, Gunter, Franke, Barbara, Wright, Margaret J, Martin, Nicholas G, Agartz, Ingrid, Alda, Martin, Alhusaini, Saud, Almasy, Laura, Almeida, Jorge, Alpert, Kathryn, Andreasen, Nancy C, Andreassen, Ole A, Apostolova, Liana G, Appel, Katja, Armstrong, Nicola J, Aribisala, Benjamin, Bastin, Mark E, Bauer, Michael, Bearden, Carrie E, Bergmann, Orjan, Binder, Elisabeth B, Blangero, John, Bockholt, Henry J, Bøen, Erlend, Bois, Catherine, Boomsma, Dorret I, Booth, Tom, Bowman, Ian J, Bralten, Janita, Brouwer, Rachel M, Brunner, Han G, Brohawn, David G, Buckner, Randy L, Buitelaar, Jan, Bulayeva, Kazima, Bustillo, Juan R, Calhoun, Vince D, Cannon, Dara M, Cantor, Rita M, Carless, Melanie A, Caseras, Xavier, Cavalleri, Gianpiero L, Chakravarty, M Mallar, Chang, Kiki D, Ching, Christopher RK, Christoforou, Andrea, Cichon, Sven, Clark, Vincent P, Conrod, Patricia, Coppola, Giovanni, Crespo-Facorro, Benedicto, Curran, Joanne E, Czisch, Michael, Deary, Ian J, de Geus, Eco JC, den Braber, Anouk, Delvecchio, Giuseppe, Depondt, Chantal, de Haan, Lieuwe, de Zubicaray, Greig I, Dima, Danai, Dimitrova, Rali, Djurovic, Srdjan, Dong, Hongwei, Donohoe, Gary, Duggirala, Ravindranath, Dyer, Thomas D, Ehrlich, Stefan, Ekman, Carl Johan, Elvsåshagen, Torbjørn, Emsell, Louise, Erk, Susanne, Espeseth, Thomas, Fagerness, Jesen, Fears, Scott, Fedko, Iryna, Fernández, Guillén, Fisher, Simon E, Foroud, Tatiana, Fox, Peter T, Francks, Clyde, Frangou, Sophia, Frey, Eva Maria, Frodl, Thomas, Frouin, Vincent, Garavan, Hugh, Giddaluru, Sudheer, Glahn, David C, Godlewska, Beata, Goldstein, Rita Z, Gollub, Randy L, Grabe, Hans J, Thompson, Paul M, Thompson, Paul M, Stein, Jason L, Medland, Sarah E, Hibar, Derrek P, Vasquez, Alejandro Arias, Renteria, Miguel E, Toro, Roberto, Jahanshad, Neda, Schumann, Gunter, Franke, Barbara, Wright, Margaret J, Martin, Nicholas G, Agartz, Ingrid, Alda, Martin, Alhusaini, Saud, Almasy, Laura, Almeida, Jorge, Alpert, Kathryn, Andreasen, Nancy C, Andreassen, Ole A, Apostolova, Liana G, Appel, Katja, Armstrong, Nicola J, Aribisala, Benjamin, Bastin, Mark E, Bauer, Michael, Bearden, Carrie E, Bergmann, Orjan, Binder, Elisabeth B, Blangero, John, Bockholt, Henry J, Bøen, Erlend, Bois, Catherine, Boomsma, Dorret I, Booth, Tom, Bowman, Ian J, Bralten, Janita, Brouwer, Rachel M, Brunner, Han G, Brohawn, David G, Buckner, Randy L, Buitelaar, Jan, Bulayeva, Kazima, Bustillo, Juan R, Calhoun, Vince D, Cannon, Dara M, Cantor, Rita M, Carless, Melanie A, Caseras, Xavier, Cavalleri, Gianpiero L, Chakravarty, M Mallar, Chang, Kiki D, Ching, Christopher RK, Christoforou, Andrea, Cichon, Sven, Clark, Vincent P, Conrod, Patricia, Coppola, Giovanni, Crespo-Facorro, Benedicto, Curran, Joanne E, Czisch, Michael, Deary, Ian J, de Geus, Eco JC, den Braber, Anouk, Delvecchio, Giuseppe, Depondt, Chantal, de Haan, Lieuwe, de Zubicaray, Greig I, Dima, Danai, Dimitrova, Rali, Djurovic, Srdjan, Dong, Hongwei, Donohoe, Gary, Duggirala, Ravindranath, Dyer, Thomas D, Ehrlich, Stefan, Ekman, Carl Johan, Elvsåshagen, Torbjørn, Emsell, Louise, Erk, Susanne, Espeseth, Thomas, Fagerness, Jesen, Fears, Scott, Fedko, Iryna, Fernández, Guillén, Fisher, Simon E, Foroud, Tatiana, Fox, Peter T, Francks, Clyde, Frangou, Sophia, Frey, Eva Maria, Frodl, Thomas, Frouin, Vincent, Garavan, Hugh, Giddaluru, Sudheer, Glahn, David C, Godlewska, Beata, Goldstein, Rita Z, Gollub, Randy L, and Grabe, Hans J
Abstract: The Enhancing NeuroImaging Genetics through Meta-Analysis (ENIGMA) Consortium is a collaborative network of researchers working together on a range of large-scale studies that integrate data from 70 institutions worldwide. Organized into Working Groups that tackle questions in neuroscience, genetics, and medicine, ENIGMA studies have analyzed neuroimaging data from over 12,826 subjects. In addition, data from 12,171 individuals were provided by the CHARGE consortium for replication of findings, in a total of 24,997 subjects. By meta-analyzing results from many sites, ENIGMA has detected factors that affect the brain that no individual site could detect on its own, and that require larger numbers of subjects than any individual neuroimaging study has currently collected. ENIGMA's first project was a genome-wide association study identifying common variants in the genome associated with hippocampal volume or intracranial volume. Continuing work is exploring genetic associations with subcortical volumes (ENIGMA2) and white matter microstructure (ENIGMA-DTI). Working groups also focus on understanding how schizophrenia, bipolar illness, major depression and attention deficit/hyperactivity disorder (ADHD) affect the brain. We review the current progress of the ENIGMA Consortium, along with challenges and unexpected discoveries made on the way.
Published: 2014

25. The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data.

Author: Thompson, Paul M, Thompson, Paul M, Stein, Jason L, Medland, Sarah E, Hibar, Derrek P, Vasquez, Alejandro Arias, Renteria, Miguel E, Toro, Roberto, Jahanshad, Neda, Schumann, Gunter, Franke, Barbara, Wright, Margaret J, Martin, Nicholas G, Agartz, Ingrid, Alda, Martin, Alhusaini, Saud, Almasy, Laura, Almeida, Jorge, Alpert, Kathryn, Andreasen, Nancy C, Andreassen, Ole A, Apostolova, Liana G, Appel, Katja, Armstrong, Nicola J, Aribisala, Benjamin, Bastin, Mark E, Bauer, Michael, Bearden, Carrie E, Bergmann, Orjan, Binder, Elisabeth B, Blangero, John, Bockholt, Henry J, Bøen, Erlend, Bois, Catherine, Boomsma, Dorret I, Booth, Tom, Bowman, Ian J, Bralten, Janita, Brouwer, Rachel M, Brunner, Han G, Brohawn, David G, Buckner, Randy L, Buitelaar, Jan, Bulayeva, Kazima, Bustillo, Juan R, Calhoun, Vince D, Cannon, Dara M, Cantor, Rita M, Carless, Melanie A, Caseras, Xavier, Cavalleri, Gianpiero L, Chakravarty, M Mallar, Chang, Kiki D, Ching, Christopher RK, Christoforou, Andrea, Cichon, Sven, Clark, Vincent P, Conrod, Patricia, Coppola, Giovanni, Crespo-Facorro, Benedicto, Curran, Joanne E, Czisch, Michael, Deary, Ian J, de Geus, Eco JC, den Braber, Anouk, Delvecchio, Giuseppe, Depondt, Chantal, de Haan, Lieuwe, de Zubicaray, Greig I, Dima, Danai, Dimitrova, Rali, Djurovic, Srdjan, Dong, Hongwei, Donohoe, Gary, Duggirala, Ravindranath, Dyer, Thomas D, Ehrlich, Stefan, Ekman, Carl Johan, Elvsåshagen, Torbjørn, Emsell, Louise, Erk, Susanne, Espeseth, Thomas, Fagerness, Jesen, Fears, Scott, Fedko, Iryna, Fernández, Guillén, Fisher, Simon E, Foroud, Tatiana, Fox, Peter T, Francks, Clyde, Frangou, Sophia, Frey, Eva Maria, Frodl, Thomas, Frouin, Vincent, Garavan, Hugh, Giddaluru, Sudheer, Glahn, David C, Godlewska, Beata, Goldstein, Rita Z, Gollub, Randy L, Grabe, Hans J, Thompson, Paul M, Thompson, Paul M, Stein, Jason L, Medland, Sarah E, Hibar, Derrek P, Vasquez, Alejandro Arias, Renteria, Miguel E, Toro, Roberto, Jahanshad, Neda, Schumann, Gunter, Franke, Barbara, Wright, Margaret J, Martin, Nicholas G, Agartz, Ingrid, Alda, Martin, Alhusaini, Saud, Almasy, Laura, Almeida, Jorge, Alpert, Kathryn, Andreasen, Nancy C, Andreassen, Ole A, Apostolova, Liana G, Appel, Katja, Armstrong, Nicola J, Aribisala, Benjamin, Bastin, Mark E, Bauer, Michael, Bearden, Carrie E, Bergmann, Orjan, Binder, Elisabeth B, Blangero, John, Bockholt, Henry J, Bøen, Erlend, Bois, Catherine, Boomsma, Dorret I, Booth, Tom, Bowman, Ian J, Bralten, Janita, Brouwer, Rachel M, Brunner, Han G, Brohawn, David G, Buckner, Randy L, Buitelaar, Jan, Bulayeva, Kazima, Bustillo, Juan R, Calhoun, Vince D, Cannon, Dara M, Cantor, Rita M, Carless, Melanie A, Caseras, Xavier, Cavalleri, Gianpiero L, Chakravarty, M Mallar, Chang, Kiki D, Ching, Christopher RK, Christoforou, Andrea, Cichon, Sven, Clark, Vincent P, Conrod, Patricia, Coppola, Giovanni, Crespo-Facorro, Benedicto, Curran, Joanne E, Czisch, Michael, Deary, Ian J, de Geus, Eco JC, den Braber, Anouk, Delvecchio, Giuseppe, Depondt, Chantal, de Haan, Lieuwe, de Zubicaray, Greig I, Dima, Danai, Dimitrova, Rali, Djurovic, Srdjan, Dong, Hongwei, Donohoe, Gary, Duggirala, Ravindranath, Dyer, Thomas D, Ehrlich, Stefan, Ekman, Carl Johan, Elvsåshagen, Torbjørn, Emsell, Louise, Erk, Susanne, Espeseth, Thomas, Fagerness, Jesen, Fears, Scott, Fedko, Iryna, Fernández, Guillén, Fisher, Simon E, Foroud, Tatiana, Fox, Peter T, Francks, Clyde, Frangou, Sophia, Frey, Eva Maria, Frodl, Thomas, Frouin, Vincent, Garavan, Hugh, Giddaluru, Sudheer, Glahn, David C, Godlewska, Beata, Goldstein, Rita Z, Gollub, Randy L, and Grabe, Hans J
Abstract: The Enhancing NeuroImaging Genetics through Meta-Analysis (ENIGMA) Consortium is a collaborative network of researchers working together on a range of large-scale studies that integrate data from 70 institutions worldwide. Organized into Working Groups that tackle questions in neuroscience, genetics, and medicine, ENIGMA studies have analyzed neuroimaging data from over 12,826 subjects. In addition, data from 12,171 individuals were provided by the CHARGE consortium for replication of findings, in a total of 24,997 subjects. By meta-analyzing results from many sites, ENIGMA has detected factors that affect the brain that no individual site could detect on its own, and that require larger numbers of subjects than any individual neuroimaging study has currently collected. ENIGMA's first project was a genome-wide association study identifying common variants in the genome associated with hippocampal volume or intracranial volume. Continuing work is exploring genetic associations with subcortical volumes (ENIGMA2) and white matter microstructure (ENIGMA-DTI). Working groups also focus on understanding how schizophrenia, bipolar illness, major depression and attention deficit/hyperactivity disorder (ADHD) affect the brain. We review the current progress of the ENIGMA Consortium, along with challenges and unexpected discoveries made on the way.
Published: 2014

26. The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data

Author: Thompson, Paul M., Stein, Jason L., Medland, Sarah E., Hibar, Derrek P., Vasquez, Alejandro Arias, Renteria, Miguel E., Toro, Roberto, Jahanshad, Neda, Schumann, Gunter, Franke, Barbara, Wright, Margaret J., Martin, Nicholas G., Agartz, Ingrid, Alda, Martin, Alhusaini, Saud, Almasy, Laura, Almeida, Jorge, Alpert, Kathryn, Andreasen, Nancy C., Andreassen, Ole A., Apostolova, Liana G., Appel, Katja, Armstrong, Nicola J., Aribisala, Benjamin, Bastin, Mark E., Bauer, Michael, Bearden, Carrie E., Bergmann, Ørjan, Binder, Elisabeth B., Blangero, John, Bockholt, Henry J., Bøen, Erlend, Bois, Catherine, Boomsma, Dorret I., Booth, Tom, Bowman, Ian J., Bralten, Janita, Brouwer, Rachel M., Brunner, Han G., Brohawn, David G., Buckner, Randy L., Buitelaar, Jan, Bulayeva, Kazima, Bustillo, Juan R., Calhoun, Vince D., Cannon, Dara M., Cantor, Rita M., Carless, Melanie A., Caseras, Xavier, Cavalleri, Gianpiero L., Chakravarty, M. Mallar, Chang, Kiki D., Ching, Christopher R. K., Christoforou, Andrea, Cichon, Sven, Clark, Vincent P., Conrod, Patricia, Coppola, Giovanni, Crespo-Facorro, Benedicto, Curran, Joanne E., Czisch, Michael, Deary, Ian J., de Geus, Eco J. C., den Braber, Anouk, Delvecchio, Giuseppe, Depondt, Chantal, de Haan, Lieuwe, de Zubicaray, Greig I., Dima, Danai, Dimitrova, Rali, Djurovic, Srdjan, Dong, Hongwei, Donohoe, Gary, Duggirala, Ravindranath, Dyer, Thomas D., Ehrlich, Stefan, Ekman, Carl Johan, Elvsåshagen, Torbjørn, Emsell, Louise, Erk, Susanne, Espeseth, Thomas, Fagerness, Jesen, Fears, Scott, Fedko, Iryna, Fernández, Guillén, Fisher, Simon E., Foroud, Tatiana, Fox, Peter T., Francks, Clyde, Frangou, Sophia, Frey, Eva Maria, Frodl, Thomas, Frouin, Vincent, Garavan, Hugh, Giddaluru, Sudheer, Glahn, David C., Godlewska, Beata, Goldstein, Rita Z., Gollub, Randy L., Grabe, Hans J., Grimm, Oliver, Gruber, Oliver, Guadalupe, Tulio, Gur, Raquel E., Gur, Ruben C., Göring, Harald H. H., Hagenaars, Saskia, Hajek, Tomas, Hall, Geoffrey B., Hall, Jeremy, Hardy, John, Hartman, Catharina A., Hass, Johanna, Hatton, Sean N., Haukvik, Unn K., Hegenscheid, Katrin, Heinz, Andreas, Hickie, Ian B., Ho, Beng-Choon, Hoehn, David, Hoekstra, Pieter J., Hollinshead, Marisa, Holmes, Avram J., Homuth, Georg, Hoogman, Martine, Hong, L. Elliot, Hosten, Norbert, Hottenga, Jouke-Jan, Hulshoff Pol, Hilleke E., Hwang, Kristy S., Jack, Clifford R., Jenkinson, Mark, Johnston, Caroline, Jönsson, Erik G., Kahn, René S., Kasperaviciute, Dalia, Kelly, Sinead, Kim, Sungeun, Kochunov, Peter, Koenders, Laura, Krämer, Bernd, Kwok, John B. J., Lagopoulos, Jim, Laje, Gonzalo, Landen, Mikael, Landman, Bennett A., Lauriello, John, Lawrie, Stephen M., Lee, Phil H., Le Hellard, Stephanie, Lemaître, Herve, Leonardo, Cassandra D., Li, Chiang-shan, Liberg, Benny, Liewald, David C., Liu, Xinmin, Lopez, Lorna M., Loth, Eva, Lourdusamy, Anbarasu, Luciano, Michelle, Macciardi, Fabio, Machielsen, Marise W. J., MacQueen, Glenda M., Malt, Ulrik F., Mandl, René, Manoach, Dara S., Martinot, Jean-Luc, Matarin, Mar, Mather, Karen A., Mattheisen, Manuel, Mattingsdal, Morten, Meyer-Lindenberg, Andreas, McDonald, Colm, McIntosh, Andrew M., McMahon, Francis J., McMahon, Katie L., Meisenzahl, Eva, Melle, Ingrid, Milaneschi, Yuri, Mohnke, Sebastian, Montgomery, Grant W., Morris, Derek W., Moses, Eric K., Mueller, Bryon A., Muñoz Maniega, Susana, Mühleisen, Thomas W., Müller-Myhsok, Bertram, Mwangi, Benson, Nauck, Matthias, Nho, Kwangsik, Nichols, Thomas E., Nilsson, Lars-Göran, Nugent, Allison C., Nyberg, Lars, Olvera, Rene L., Oosterlaan, Jaap, Ophoff, Roel A., Pandolfo, Massimo, Papalampropoulou-Tsiridou, Melina, Papmeyer, Martina, Paus, Tomas, Pausova, Zdenka, Pearlson, Godfrey D., Penninx, Brenda W., Peterson, Charles P., Pfennig, Andrea, Phillips, Mary, Pike, G. Bruce, Poline, Jean-Baptiste, Potkin, Steven G., Pütz, Benno, Ramasamy, Adaikalavan, Rasmussen, Jerod, Rietschel, Marcella, Rijpkema, Mark, Risacher, Shannon L., Roffman, Joshua L., Roiz-Santiañez, Roberto, Romanczuk-Seiferth, Nina, Rose, Emma J., Royle, Natalie A., Rujescu, Dan, Ryten, Mina, Sachdev, Perminder S., Salami, Alireza, Satterthwaite, Theodore D., Savitz, Jonathan, Saykin, Andrew J., Scanlon, Cathy, Schmaal, Lianne, Schnack, Hugo G., Schork, Andrew J., Schulz, S. Charles, Schür, Remmelt, Seidman, Larry, Shen, Li, Shoemaker, Jody M., Simmons, Andrew, Sisodiya, Sanjay M., Smith, Colin, Smoller, Jordan W., Soares, Jair C., Sponheim, Scott R., Sprooten, Emma, Starr, John M., Steen, Vidar M., Strakowski, Stephen, Strike, Lachlan, Sussmann, Jessika, Sämann, Philipp G., Teumer, Alexander, Toga, Arthur W., Tordesillas-Gutierrez, Diana, Trabzuni, Daniah, Trost, Sarah, Turner, Jessica, Van den Heuvel, Martijn, van der Wee, Nic J., van Eijk, Kristel, van Erp, Theo G. M., van Haren, Neeltje E. M., van ‘t Ent, Dennis, van Tol, Marie-Jose, Valdés Hernández, Maria C., Veltman, Dick J., Versace, Amelia, Völzke, Henry, Walker, Robert, Walter, Henrik, Wang, Lei, Wardlaw, Joanna M., Weale, Michael E., Weiner, Michael W., Wen, Wei, Westlye, Lars T., Whalley, Heather C., Whelan, Christopher D., White, Tonya, Winkler, Anderson M., Wittfeld, Katharina, Woldehawariat, Girma, Wolf, Christiane, Zilles, David, Zwiers, Marcel P., Thalamuthu, Anbupalam, Schofield, Peter R., Freimer, Nelson B., Lawrence, Natalia S., Drevets, Wayne, Thompson, Paul M., Stein, Jason L., Medland, Sarah E., Hibar, Derrek P., Vasquez, Alejandro Arias, Renteria, Miguel E., Toro, Roberto, Jahanshad, Neda, Schumann, Gunter, Franke, Barbara, Wright, Margaret J., Martin, Nicholas G., Agartz, Ingrid, Alda, Martin, Alhusaini, Saud, Almasy, Laura, Almeida, Jorge, Alpert, Kathryn, Andreasen, Nancy C., Andreassen, Ole A., Apostolova, Liana G., Appel, Katja, Armstrong, Nicola J., Aribisala, Benjamin, Bastin, Mark E., Bauer, Michael, Bearden, Carrie E., Bergmann, Ørjan, Binder, Elisabeth B., Blangero, John, Bockholt, Henry J., Bøen, Erlend, Bois, Catherine, Boomsma, Dorret I., Booth, Tom, Bowman, Ian J., Bralten, Janita, Brouwer, Rachel M., Brunner, Han G., Brohawn, David G., Buckner, Randy L., Buitelaar, Jan, Bulayeva, Kazima, Bustillo, Juan R., Calhoun, Vince D., Cannon, Dara M., Cantor, Rita M., Carless, Melanie A., Caseras, Xavier, Cavalleri, Gianpiero L., Chakravarty, M. Mallar, Chang, Kiki D., Ching, Christopher R. K., Christoforou, Andrea, Cichon, Sven, Clark, Vincent P., Conrod, Patricia, Coppola, Giovanni, Crespo-Facorro, Benedicto, Curran, Joanne E., Czisch, Michael, Deary, Ian J., de Geus, Eco J. C., den Braber, Anouk, Delvecchio, Giuseppe, Depondt, Chantal, de Haan, Lieuwe, de Zubicaray, Greig I., Dima, Danai, Dimitrova, Rali, Djurovic, Srdjan, Dong, Hongwei, Donohoe, Gary, Duggirala, Ravindranath, Dyer, Thomas D., Ehrlich, Stefan, Ekman, Carl Johan, Elvsåshagen, Torbjørn, Emsell, Louise, Erk, Susanne, Espeseth, Thomas, Fagerness, Jesen, Fears, Scott, Fedko, Iryna, Fernández, Guillén, Fisher, Simon E., Foroud, Tatiana, Fox, Peter T., Francks, Clyde, Frangou, Sophia, Frey, Eva Maria, Frodl, Thomas, Frouin, Vincent, Garavan, Hugh, Giddaluru, Sudheer, Glahn, David C., Godlewska, Beata, Goldstein, Rita Z., Gollub, Randy L., Grabe, Hans J., Grimm, Oliver, Gruber, Oliver, Guadalupe, Tulio, Gur, Raquel E., Gur, Ruben C., Göring, Harald H. H., Hagenaars, Saskia, Hajek, Tomas, Hall, Geoffrey B., Hall, Jeremy, Hardy, John, Hartman, Catharina A., Hass, Johanna, Hatton, Sean N., Haukvik, Unn K., Hegenscheid, Katrin, Heinz, Andreas, Hickie, Ian B., Ho, Beng-Choon, Hoehn, David, Hoekstra, Pieter J., Hollinshead, Marisa, Holmes, Avram J., Homuth, Georg, Hoogman, Martine, Hong, L. Elliot, Hosten, Norbert, Hottenga, Jouke-Jan, Hulshoff Pol, Hilleke E., Hwang, Kristy S., Jack, Clifford R., Jenkinson, Mark, Johnston, Caroline, Jönsson, Erik G., Kahn, René S., Kasperaviciute, Dalia, Kelly, Sinead, Kim, Sungeun, Kochunov, Peter, Koenders, Laura, Krämer, Bernd, Kwok, John B. J., Lagopoulos, Jim, Laje, Gonzalo, Landen, Mikael, Landman, Bennett A., Lauriello, John, Lawrie, Stephen M., Lee, Phil H., Le Hellard, Stephanie, Lemaître, Herve, Leonardo, Cassandra D., Li, Chiang-shan, Liberg, Benny, Liewald, David C., Liu, Xinmin, Lopez, Lorna M., Loth, Eva, Lourdusamy, Anbarasu, Luciano, Michelle, Macciardi, Fabio, Machielsen, Marise W. J., MacQueen, Glenda M., Malt, Ulrik F., Mandl, René, Manoach, Dara S., Martinot, Jean-Luc, Matarin, Mar, Mather, Karen A., Mattheisen, Manuel, Mattingsdal, Morten, Meyer-Lindenberg, Andreas, McDonald, Colm, McIntosh, Andrew M., McMahon, Francis J., McMahon, Katie L., Meisenzahl, Eva, Melle, Ingrid, Milaneschi, Yuri, Mohnke, Sebastian, Montgomery, Grant W., Morris, Derek W., Moses, Eric K., Mueller, Bryon A., Muñoz Maniega, Susana, Mühleisen, Thomas W., Müller-Myhsok, Bertram, Mwangi, Benson, Nauck, Matthias, Nho, Kwangsik, Nichols, Thomas E., Nilsson, Lars-Göran, Nugent, Allison C., Nyberg, Lars, Olvera, Rene L., Oosterlaan, Jaap, Ophoff, Roel A., Pandolfo, Massimo, Papalampropoulou-Tsiridou, Melina, Papmeyer, Martina, Paus, Tomas, Pausova, Zdenka, Pearlson, Godfrey D., Penninx, Brenda W., Peterson, Charles P., Pfennig, Andrea, Phillips, Mary, Pike, G. Bruce, Poline, Jean-Baptiste, Potkin, Steven G., Pütz, Benno, Ramasamy, Adaikalavan, Rasmussen, Jerod, Rietschel, Marcella, Rijpkema, Mark, Risacher, Shannon L., Roffman, Joshua L., Roiz-Santiañez, Roberto, Romanczuk-Seiferth, Nina, Rose, Emma J., Royle, Natalie A., Rujescu, Dan, Ryten, Mina, Sachdev, Perminder S., Salami, Alireza, Satterthwaite, Theodore D., Savitz, Jonathan, Saykin, Andrew J., Scanlon, Cathy, Schmaal, Lianne, Schnack, Hugo G., Schork, Andrew J., Schulz, S. Charles, Schür, Remmelt, Seidman, Larry, Shen, Li, Shoemaker, Jody M., Simmons, Andrew, Sisodiya, Sanjay M., Smith, Colin, Smoller, Jordan W., Soares, Jair C., Sponheim, Scott R., Sprooten, Emma, Starr, John M., Steen, Vidar M., Strakowski, Stephen, Strike, Lachlan, Sussmann, Jessika, Sämann, Philipp G., Teumer, Alexander, Toga, Arthur W., Tordesillas-Gutierrez, Diana, Trabzuni, Daniah, Trost, Sarah, Turner, Jessica, Van den Heuvel, Martijn, van der Wee, Nic J., van Eijk, Kristel, van Erp, Theo G. M., van Haren, Neeltje E. M., van ‘t Ent, Dennis, van Tol, Marie-Jose, Valdés Hernández, Maria C., Veltman, Dick J., Versace, Amelia, Völzke, Henry, Walker, Robert, Walter, Henrik, Wang, Lei, Wardlaw, Joanna M., Weale, Michael E., Weiner, Michael W., Wen, Wei, Westlye, Lars T., Whalley, Heather C., Whelan, Christopher D., White, Tonya, Winkler, Anderson M., Wittfeld, Katharina, Woldehawariat, Girma, Wolf, Christiane, Zilles, David, Zwiers, Marcel P., Thalamuthu, Anbupalam, Schofield, Peter R., Freimer, Nelson B., Lawrence, Natalia S., and Drevets, Wayne
Abstract: The Enhancing NeuroImaging Genetics through Meta-Analysis (ENIGMA) Consortium is a collaborative network of researchers working together on a range of large-scale studies that integrate data from 70 institutions worldwide. Organized into Working Groups that tackle questions in neuroscience, genetics, and medicine, ENIGMA studies have analyzed neuroimaging data from over 12,826 subjects. In addition, data from 12,171 individuals were provided by the CHARGE consortium for replication of findings, in a total of 24,997 subjects. By meta-analyzing results from many sites, ENIGMA has detected factors that affect the brain that no individual site could detect on its own, and that require larger numbers of subjects than any individual neuroimaging study has currently collected. ENIGMA's first project was a genome-wide association study identifying common variants in the genome associated with hippocampal volume or intracranial volume. Continuing work is exploring genetic associations with subcortical volumes (ENIGMA2) and white matter microstructure (ENIGMA-DTI). Working groups also focus on understanding how schizophrenia, bipolar illness, major depression and attention deficit/hyperactivity disorder (ADHD) affect the brain. We review the current progress of the ENIGMA Consortium, along with challenges and unexpected discoveries made on the way.
Published: 2014

27. The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data

Author: Thompson, Paul M., Stein, Jason L., Medland, Sarah E., Hibar, Derrek P., Vasquez, Alejandro Arias, Renteria, Miguel E., Toro, Roberto, Jahanshad, Neda, Schumann, Gunter, Franke, Barbara, Wright, Margaret J., Martin, Nicholas G., Agartz, Ingrid, Alda, Martin, Alhusaini, Saud, Almasy, Laura, Almeida, Jorge, Alpert, Kathryn, Andreasen, Nancy C., Andreassen, Ole A., Apostolova, Liana G., Appel, Katja, Armstrong, Nicola J., Aribisala, Benjamin, Bastin, Mark E., Bauer, Michael, Bearden, Carrie E., Bergmann, Ørjan, Binder, Elisabeth B., Blangero, John, Bockholt, Henry J., Bøen, Erlend, Bois, Catherine, Boomsma, Dorret I., Booth, Tom, Bowman, Ian J., Bralten, Janita, Brouwer, Rachel M., Brunner, Han G., Brohawn, David G., Buckner, Randy L., Buitelaar, Jan, Bulayeva, Kazima, Bustillo, Juan R., Calhoun, Vince D., Cannon, Dara M., Cantor, Rita M., Carless, Melanie A., Caseras, Xavier, Cavalleri, Gianpiero L., Chakravarty, M. Mallar, Chang, Kiki D., Ching, Christopher R. K., Christoforou, Andrea, Cichon, Sven, Clark, Vincent P., Conrod, Patricia, Coppola, Giovanni, Crespo-Facorro, Benedicto, Curran, Joanne E., Czisch, Michael, Deary, Ian J., de Geus, Eco J. C., den Braber, Anouk, Delvecchio, Giuseppe, Depondt, Chantal, de Haan, Lieuwe, de Zubicaray, Greig I., Dima, Danai, Dimitrova, Rali, Djurovic, Srdjan, Dong, Hongwei, Donohoe, Gary, Duggirala, Ravindranath, Dyer, Thomas D., Ehrlich, Stefan, Ekman, Carl Johan, Elvsåshagen, Torbjørn, Emsell, Louise, Erk, Susanne, Espeseth, Thomas, Fagerness, Jesen, Fears, Scott, Fedko, Iryna, Fernández, Guillén, Fisher, Simon E., Foroud, Tatiana, Fox, Peter T., Francks, Clyde, Frangou, Sophia, Frey, Eva Maria, Frodl, Thomas, Frouin, Vincent, Garavan, Hugh, Giddaluru, Sudheer, Glahn, David C., Godlewska, Beata, Goldstein, Rita Z., Gollub, Randy L., Grabe, Hans J., Grimm, Oliver, Gruber, Oliver, Guadalupe, Tulio, Gur, Raquel E., Gur, Ruben C., Göring, Harald H. H., Hagenaars, Saskia, Hajek, Tomas, Hall, Geoffrey B., Hall, Jeremy, Hardy, John, Hartman, Catharina A., Hass, Johanna, Hatton, Sean N., Haukvik, Unn K., Hegenscheid, Katrin, Heinz, Andreas, Hickie, Ian B., Ho, Beng-Choon, Hoehn, David, Hoekstra, Pieter J., Hollinshead, Marisa, Holmes, Avram J., Homuth, Georg, Hoogman, Martine, Hong, L. Elliot, Hosten, Norbert, Hottenga, Jouke-Jan, Hulshoff Pol, Hilleke E., Hwang, Kristy S., Jack, Clifford R., Jenkinson, Mark, Johnston, Caroline, Jönsson, Erik G., Kahn, René S., Kasperaviciute, Dalia, Kelly, Sinead, Kim, Sungeun, Kochunov, Peter, Koenders, Laura, Krämer, Bernd, Kwok, John B. J., Lagopoulos, Jim, Laje, Gonzalo, Landen, Mikael, Landman, Bennett A., Lauriello, John, Lawrie, Stephen M., Lee, Phil H., Le Hellard, Stephanie, Lemaître, Herve, Leonardo, Cassandra D., Li, Chiang-shan, Liberg, Benny, Liewald, David C., Liu, Xinmin, Lopez, Lorna M., Loth, Eva, Lourdusamy, Anbarasu, Luciano, Michelle, Macciardi, Fabio, Machielsen, Marise W. J., MacQueen, Glenda M., Malt, Ulrik F., Mandl, René, Manoach, Dara S., Martinot, Jean-Luc, Matarin, Mar, Mather, Karen A., Mattheisen, Manuel, Mattingsdal, Morten, Meyer-Lindenberg, Andreas, McDonald, Colm, McIntosh, Andrew M., McMahon, Francis J., McMahon, Katie L., Meisenzahl, Eva, Melle, Ingrid, Milaneschi, Yuri, Mohnke, Sebastian, Montgomery, Grant W., Morris, Derek W., Moses, Eric K., Mueller, Bryon A., Muñoz Maniega, Susana, Mühleisen, Thomas W., Müller-Myhsok, Bertram, Mwangi, Benson, Nauck, Matthias, Nho, Kwangsik, Nichols, Thomas E., Nilsson, Lars-Göran, Nugent, Allison C., Nyberg, Lars, Olvera, Rene L., Oosterlaan, Jaap, Ophoff, Roel A., Pandolfo, Massimo, Papalampropoulou-Tsiridou, Melina, Papmeyer, Martina, Paus, Tomas, Pausova, Zdenka, Pearlson, Godfrey D., Penninx, Brenda W., Peterson, Charles P., Pfennig, Andrea, Phillips, Mary, Pike, G. Bruce, Poline, Jean-Baptiste, Potkin, Steven G., Pütz, Benno, Ramasamy, Adaikalavan, Rasmussen, Jerod, Rietschel, Marcella, Rijpkema, Mark, Risacher, Shannon L., Roffman, Joshua L., Roiz-Santiañez, Roberto, Romanczuk-Seiferth, Nina, Rose, Emma J., Royle, Natalie A., Rujescu, Dan, Ryten, Mina, Sachdev, Perminder S., Salami, Alireza, Satterthwaite, Theodore D., Savitz, Jonathan, Saykin, Andrew J., Scanlon, Cathy, Schmaal, Lianne, Schnack, Hugo G., Schork, Andrew J., Schulz, S. Charles, Schür, Remmelt, Seidman, Larry, Shen, Li, Shoemaker, Jody M., Simmons, Andrew, Sisodiya, Sanjay M., Smith, Colin, Smoller, Jordan W., Soares, Jair C., Sponheim, Scott R., Sprooten, Emma, Starr, John M., Steen, Vidar M., Strakowski, Stephen, Strike, Lachlan, Sussmann, Jessika, Sämann, Philipp G., Teumer, Alexander, Toga, Arthur W., Tordesillas-Gutierrez, Diana, Trabzuni, Daniah, Trost, Sarah, Turner, Jessica, Van den Heuvel, Martijn, van der Wee, Nic J., van Eijk, Kristel, van Erp, Theo G. M., van Haren, Neeltje E. M., van ‘t Ent, Dennis, van Tol, Marie-Jose, Valdés Hernández, Maria C., Veltman, Dick J., Versace, Amelia, Völzke, Henry, Walker, Robert, Walter, Henrik, Wang, Lei, Wardlaw, Joanna M., Weale, Michael E., Weiner, Michael W., Wen, Wei, Westlye, Lars T., Whalley, Heather C., Whelan, Christopher D., White, Tonya, Winkler, Anderson M., Wittfeld, Katharina, Woldehawariat, Girma, Wolf, Christiane, Zilles, David, Zwiers, Marcel P., Thalamuthu, Anbupalam, Schofield, Peter R., Freimer, Nelson B., Lawrence, Natalia S., Drevets, Wayne, Thompson, Paul M., Stein, Jason L., Medland, Sarah E., Hibar, Derrek P., Vasquez, Alejandro Arias, Renteria, Miguel E., Toro, Roberto, Jahanshad, Neda, Schumann, Gunter, Franke, Barbara, Wright, Margaret J., Martin, Nicholas G., Agartz, Ingrid, Alda, Martin, Alhusaini, Saud, Almasy, Laura, Almeida, Jorge, Alpert, Kathryn, Andreasen, Nancy C., Andreassen, Ole A., Apostolova, Liana G., Appel, Katja, Armstrong, Nicola J., Aribisala, Benjamin, Bastin, Mark E., Bauer, Michael, Bearden, Carrie E., Bergmann, Ørjan, Binder, Elisabeth B., Blangero, John, Bockholt, Henry J., Bøen, Erlend, Bois, Catherine, Boomsma, Dorret I., Booth, Tom, Bowman, Ian J., Bralten, Janita, Brouwer, Rachel M., Brunner, Han G., Brohawn, David G., Buckner, Randy L., Buitelaar, Jan, Bulayeva, Kazima, Bustillo, Juan R., Calhoun, Vince D., Cannon, Dara M., Cantor, Rita M., Carless, Melanie A., Caseras, Xavier, Cavalleri, Gianpiero L., Chakravarty, M. Mallar, Chang, Kiki D., Ching, Christopher R. K., Christoforou, Andrea, Cichon, Sven, Clark, Vincent P., Conrod, Patricia, Coppola, Giovanni, Crespo-Facorro, Benedicto, Curran, Joanne E., Czisch, Michael, Deary, Ian J., de Geus, Eco J. C., den Braber, Anouk, Delvecchio, Giuseppe, Depondt, Chantal, de Haan, Lieuwe, de Zubicaray, Greig I., Dima, Danai, Dimitrova, Rali, Djurovic, Srdjan, Dong, Hongwei, Donohoe, Gary, Duggirala, Ravindranath, Dyer, Thomas D., Ehrlich, Stefan, Ekman, Carl Johan, Elvsåshagen, Torbjørn, Emsell, Louise, Erk, Susanne, Espeseth, Thomas, Fagerness, Jesen, Fears, Scott, Fedko, Iryna, Fernández, Guillén, Fisher, Simon E., Foroud, Tatiana, Fox, Peter T., Francks, Clyde, Frangou, Sophia, Frey, Eva Maria, Frodl, Thomas, Frouin, Vincent, Garavan, Hugh, Giddaluru, Sudheer, Glahn, David C., Godlewska, Beata, Goldstein, Rita Z., Gollub, Randy L., Grabe, Hans J., Grimm, Oliver, Gruber, Oliver, Guadalupe, Tulio, Gur, Raquel E., Gur, Ruben C., Göring, Harald H. H., Hagenaars, Saskia, Hajek, Tomas, Hall, Geoffrey B., Hall, Jeremy, Hardy, John, Hartman, Catharina A., Hass, Johanna, Hatton, Sean N., Haukvik, Unn K., Hegenscheid, Katrin, Heinz, Andreas, Hickie, Ian B., Ho, Beng-Choon, Hoehn, David, Hoekstra, Pieter J., Hollinshead, Marisa, Holmes, Avram J., Homuth, Georg, Hoogman, Martine, Hong, L. Elliot, Hosten, Norbert, Hottenga, Jouke-Jan, Hulshoff Pol, Hilleke E., Hwang, Kristy S., Jack, Clifford R., Jenkinson, Mark, Johnston, Caroline, Jönsson, Erik G., Kahn, René S., Kasperaviciute, Dalia, Kelly, Sinead, Kim, Sungeun, Kochunov, Peter, Koenders, Laura, Krämer, Bernd, Kwok, John B. J., Lagopoulos, Jim, Laje, Gonzalo, Landen, Mikael, Landman, Bennett A., Lauriello, John, Lawrie, Stephen M., Lee, Phil H., Le Hellard, Stephanie, Lemaître, Herve, Leonardo, Cassandra D., Li, Chiang-shan, Liberg, Benny, Liewald, David C., Liu, Xinmin, Lopez, Lorna M., Loth, Eva, Lourdusamy, Anbarasu, Luciano, Michelle, Macciardi, Fabio, Machielsen, Marise W. J., MacQueen, Glenda M., Malt, Ulrik F., Mandl, René, Manoach, Dara S., Martinot, Jean-Luc, Matarin, Mar, Mather, Karen A., Mattheisen, Manuel, Mattingsdal, Morten, Meyer-Lindenberg, Andreas, McDonald, Colm, McIntosh, Andrew M., McMahon, Francis J., McMahon, Katie L., Meisenzahl, Eva, Melle, Ingrid, Milaneschi, Yuri, Mohnke, Sebastian, Montgomery, Grant W., Morris, Derek W., Moses, Eric K., Mueller, Bryon A., Muñoz Maniega, Susana, Mühleisen, Thomas W., Müller-Myhsok, Bertram, Mwangi, Benson, Nauck, Matthias, Nho, Kwangsik, Nichols, Thomas E., Nilsson, Lars-Göran, Nugent, Allison C., Nyberg, Lars, Olvera, Rene L., Oosterlaan, Jaap, Ophoff, Roel A., Pandolfo, Massimo, Papalampropoulou-Tsiridou, Melina, Papmeyer, Martina, Paus, Tomas, Pausova, Zdenka, Pearlson, Godfrey D., Penninx, Brenda W., Peterson, Charles P., Pfennig, Andrea, Phillips, Mary, Pike, G. Bruce, Poline, Jean-Baptiste, Potkin, Steven G., Pütz, Benno, Ramasamy, Adaikalavan, Rasmussen, Jerod, Rietschel, Marcella, Rijpkema, Mark, Risacher, Shannon L., Roffman, Joshua L., Roiz-Santiañez, Roberto, Romanczuk-Seiferth, Nina, Rose, Emma J., Royle, Natalie A., Rujescu, Dan, Ryten, Mina, Sachdev, Perminder S., Salami, Alireza, Satterthwaite, Theodore D., Savitz, Jonathan, Saykin, Andrew J., Scanlon, Cathy, Schmaal, Lianne, Schnack, Hugo G., Schork, Andrew J., Schulz, S. Charles, Schür, Remmelt, Seidman, Larry, Shen, Li, Shoemaker, Jody M., Simmons, Andrew, Sisodiya, Sanjay M., Smith, Colin, Smoller, Jordan W., Soares, Jair C., Sponheim, Scott R., Sprooten, Emma, Starr, John M., Steen, Vidar M., Strakowski, Stephen, Strike, Lachlan, Sussmann, Jessika, Sämann, Philipp G., Teumer, Alexander, Toga, Arthur W., Tordesillas-Gutierrez, Diana, Trabzuni, Daniah, Trost, Sarah, Turner, Jessica, Van den Heuvel, Martijn, van der Wee, Nic J., van Eijk, Kristel, van Erp, Theo G. M., van Haren, Neeltje E. M., van ‘t Ent, Dennis, van Tol, Marie-Jose, Valdés Hernández, Maria C., Veltman, Dick J., Versace, Amelia, Völzke, Henry, Walker, Robert, Walter, Henrik, Wang, Lei, Wardlaw, Joanna M., Weale, Michael E., Weiner, Michael W., Wen, Wei, Westlye, Lars T., Whalley, Heather C., Whelan, Christopher D., White, Tonya, Winkler, Anderson M., Wittfeld, Katharina, Woldehawariat, Girma, Wolf, Christiane, Zilles, David, Zwiers, Marcel P., Thalamuthu, Anbupalam, Schofield, Peter R., Freimer, Nelson B., Lawrence, Natalia S., and Drevets, Wayne
Abstract: The Enhancing NeuroImaging Genetics through Meta-Analysis (ENIGMA) Consortium is a collaborative network of researchers working together on a range of large-scale studies that integrate data from 70 institutions worldwide. Organized into Working Groups that tackle questions in neuroscience, genetics, and medicine, ENIGMA studies have analyzed neuroimaging data from over 12,826 subjects. In addition, data from 12,171 individuals were provided by the CHARGE consortium for replication of findings, in a total of 24,997 subjects. By meta-analyzing results from many sites, ENIGMA has detected factors that affect the brain that no individual site could detect on its own, and that require larger numbers of subjects than any individual neuroimaging study has currently collected. ENIGMA's first project was a genome-wide association study identifying common variants in the genome associated with hippocampal volume or intracranial volume. Continuing work is exploring genetic associations with subcortical volumes (ENIGMA2) and white matter microstructure (ENIGMA-DTI). Working groups also focus on understanding how schizophrenia, bipolar illness, major depression and attention deficit/hyperactivity disorder (ADHD) affect the brain. We review the current progress of the ENIGMA Consortium, along with challenges and unexpected discoveries made on the way.
Published: 2014

28. Association between Dopamine D4 Receptor Polymorphism and Age Related Changes in Brain Glucose Metabolism

Author: Volkow, Nora D., Volkow, Nora D., Tomasi, Dardo, Wang, Gene-Jack, Telang, Frank, Fowler, Joanna S., Goldstein, Rita Z., Klein, Nelly, Wong, Christopher, Swanson, James M., Shumay, Elena, Volkow, Nora D., Volkow, Nora D., Tomasi, Dardo, Wang, Gene-Jack, Telang, Frank, Fowler, Joanna S., Goldstein, Rita Z., Klein, Nelly, Wong, Christopher, Swanson, James M., and Shumay, Elena
Abstract: Aging is associated with reductions in brain glucose metabolism in some cortical and subcortical regions, but the rate of decrease varies significantly between individuals, likely reflecting genetic and environmental factors and their interactions. Here we test the hypothesis that the variant of the dopamine receptor D4 (DRD4) gene (VNTR in exon 3), which has been associated with novelty seeking and sensitivity to environmental stimuli (negative and positive) including the beneficial effects of physical activity on longevity, influence the effects of aging on the human brain. We used positron emission tomography (PET) and [18F]fluoro-D-glucose (18FDG) to measure brain glucose metabolism (marker of brain function) under baseline conditions (no stimulation) in 82 healthy individuals (age range 22–55 years). We determined their DRD4 genotype and found an interaction with age: individuals who did not carry the 7-repeat allele (7R−, n = 53) had a significant (p<0.0001) negative association between age and relative glucose metabolism (normalized to whole brain glucose metabolism) in frontal (r = −0.52), temporal (r = −0.51) and striatal regions (r = −0.47, p<0.001); such that older individuals had lower metabolism than younger ones. In contrast, for carriers of the 7R allele (7R+ n = 29), these correlations with age were not significant and they only showed a positive association with cerebellar glucose metabolism (r = +0.55; p = 0.002). Regression slopes of regional brain glucose metabolism with age differed significantly between the 7R+ and 7R− groups in cerebellum, inferior temporal cortex and striatum. These results provide evidence that the DRD4 genotype might modulate the associations between regional brain glucose metabolism and age and that the carriers of the 7R allele appear to be less sensitive to the effects of age on brain glucose metabolism.
Published: 2013

29. Association between Dopamine D4 Receptor Polymorphism and Age Related Changes in Brain Glucose Metabolism

Author: Volkow, Nora D., Volkow, Nora D., Tomasi, Dardo, Wang, Gene-Jack, Telang, Frank, Fowler, Joanna S., Goldstein, Rita Z., Klein, Nelly, Wong, Christopher, Swanson, James M., Shumay, Elena, Volkow, Nora D., Volkow, Nora D., Tomasi, Dardo, Wang, Gene-Jack, Telang, Frank, Fowler, Joanna S., Goldstein, Rita Z., Klein, Nelly, Wong, Christopher, Swanson, James M., and Shumay, Elena
Abstract: Aging is associated with reductions in brain glucose metabolism in some cortical and subcortical regions, but the rate of decrease varies significantly between individuals, likely reflecting genetic and environmental factors and their interactions. Here we test the hypothesis that the variant of the dopamine receptor D4 (DRD4) gene (VNTR in exon 3), which has been associated with novelty seeking and sensitivity to environmental stimuli (negative and positive) including the beneficial effects of physical activity on longevity, influence the effects of aging on the human brain. We used positron emission tomography (PET) and [18F]fluoro-D-glucose (18FDG) to measure brain glucose metabolism (marker of brain function) under baseline conditions (no stimulation) in 82 healthy individuals (age range 22–55 years). We determined their DRD4 genotype and found an interaction with age: individuals who did not carry the 7-repeat allele (7R−, n = 53) had a significant (p<0.0001) negative association between age and relative glucose metabolism (normalized to whole brain glucose metabolism) in frontal (r = −0.52), temporal (r = −0.51) and striatal regions (r = −0.47, p<0.001); such that older individuals had lower metabolism than younger ones. In contrast, for carriers of the 7R allele (7R+ n = 29), these correlations with age were not significant and they only showed a positive association with cerebellar glucose metabolism (r = +0.55; p = 0.002). Regression slopes of regional brain glucose metabolism with age differed significantly between the 7R+ and 7R− groups in cerebellum, inferior temporal cortex and striatum. These results provide evidence that the DRD4 genotype might modulate the associations between regional brain glucose metabolism and age and that the carriers of the 7R allele appear to be less sensitive to the effects of age on brain glucose metabolism.
Published: 2013

Catalog

Books, media, physical & digital resources

See catalog results

Searchworks

Select search scope, currently: Articles

Catalog

books, media & more in Jio Institute collections

Articles

journal articles & other e-resources

Refine your results

29 results on '"Goldstein, Rita Z."'

1. Parameter Space and Potential for Biomarker Development in 25 Years of fMRI Drug Cue Reactivity

2. A methodological checklist for fMRI drug cue reactivity studies : development and expert consensus

3. A methodological checklist for fMRI drug cue reactivity studies : development and expert consensus

4. A methodological checklist for fMRI drug cue reactivity studies : development and expert consensus

5. White matter microstructure differences in individuals with dependence on cocaine, methamphetamine, and nicotine: Findings from the ENIGMA-Addiction working group.

6. A methodological checklist for fMRI drug cue reactivity studies: development and expert consensus.

7. A methodological checklist for fMRI drug cue reactivity studies : development and expert consensus

8. A methodological checklist for fMRI drug cue reactivity studies : development and expert consensus

9. A methodological checklist for fMRI drug cue reactivity studies : development and expert consensus

10. Self-awareness of problematic drug use: Preliminary validation of a new fMRI task to assess underlying neurocircuitry.

11. Self-awareness of problematic drug use: Preliminary validation of a new fMRI task to assess underlying neurocircuitry.

12. A transdiagnostic dimensional approach towards a neuropsychological assessment for addiction: an international Delphi consensus study.

13. A transdiagnostic dimensional approach towards a neuropsychological assessment for addiction: an international Delphi consensus study.

14. Mega-Analysis of Gray Matter Volume in Substance Dependence: General and Substance-Specific Regional Effects.

15. Adolescent brain cognitive development (ABCD) study: Overview of substance use assessment methods.

16. Low Striatal Dopamine D2-type Receptor Availability is Linked to Simulated Drug Choice in Methamphetamine Users.

17. Adolescent brain cognitive development (ABCD) study: Overview of substance use assessment methods.

18. Low Striatal Dopamine D2-type Receptor Availability is Linked to Simulated Drug Choice in Methamphetamine Users.

19. Low Striatal Dopamine D2-type Receptor Availability is Linked to Simulated Drug Choice in Methamphetamine Users

20. The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data

21. Genetic imaging consortium for addiction medicine: From neuroimaging to genes.

22. Genetic imaging consortium for addiction medicine: From neuroimaging to genes.

23. The ENIGMA Consortium : large-scale collaborative analyses of neuroimaging and genetic data

24. The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data.

25. The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data.

26. The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data

27. The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data

28. Association between Dopamine D4 Receptor Polymorphism and Age Related Changes in Brain Glucose Metabolism

29. Association between Dopamine D4 Receptor Polymorphism and Age Related Changes in Brain Glucose Metabolism

Catalog

Searchworks

Select search scope, currently: Articles Catalog books, media & more in Jio Institute collections Articles journal articles & other e-resources

Search

Search Constraints

Refine your results

Search Limiters

Publication Year Range

Publication Type

Database

Publisher

29 results on '"Goldstein, Rita Z."'

Search Results

Catalog

Select search scope, currently: Articles

Catalog

books, media & more in Jio Institute collections

Articles

journal articles & other e-resources